| ABL1-201 |
P00519 |
ABL1 |
Tyrosine-protein kinase ABL1 |
chr9 |
PF07714 |
242 |
493 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| ABL1-201 |
P00519 |
ABL1 |
Tyrosine-protein kinase ABL1 |
chr9 |
PF00018 |
67 |
113 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| ABL1-202 |
P00519 |
ABL1 |
Tyrosine-protein kinase ABL1 |
chr9 |
PF07714 |
242 |
493 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| ABL1-202 |
P00519 |
ABL1 |
Tyrosine-protein kinase ABL1 |
chr9 |
PF00018 |
67 |
113 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| ACE-204 |
P12821 |
ACE |
Angiotensin-converting enzyme |
chr17 |
PF01401 |
643 |
1221 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| ACE-202 |
P12821 |
ACE |
Angiotensin-converting enzyme |
chr17 |
PF01401 |
643 |
1221 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| AKT1-206 |
P31749 |
AKT1 |
RAC-alpha serine/threonine-protein kinase |
chr14 |
PF00433 |
429 |
474 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| AKT1-213 |
P31749 |
AKT1 |
RAC-alpha serine/threonine-protein kinase |
chr14 |
PF00433 |
429 |
474 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| AKT1-221 |
P31749 |
AKT1 |
RAC-alpha serine/threonine-protein kinase |
chr14 |
PF00433 |
429 |
474 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| AKT1-214 |
P31749 |
AKT1 |
RAC-alpha serine/threonine-protein kinase |
chr14 |
PF00433 |
429 |
474 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| AKT1-218 |
P31749 |
AKT1 |
RAC-alpha serine/threonine-protein kinase |
chr14 |
PF00433 |
429 |
474 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| AKT1-208 |
P31749 |
AKT1 |
RAC-alpha serine/threonine-protein kinase |
chr14 |
PF00433 |
429 |
474 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| AKT1-201 |
P31749 |
AKT1 |
RAC-alpha serine/threonine-protein kinase |
chr14 |
PF00433 |
429 |
474 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| AKT1-211 |
P31749 |
AKT1 |
RAC-alpha serine/threonine-protein kinase |
chr14 |
PF00433 |
429 |
474 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| AKT1-203 |
P31749 |
AKT1 |
RAC-alpha serine/threonine-protein kinase |
chr14 |
PF00433 |
429 |
474 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| AKT1-202 |
P31749 |
AKT1 |
RAC-alpha serine/threonine-protein kinase |
chr14 |
PF00433 |
429 |
474 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| AKT1-209 |
P31749 |
AKT1 |
RAC-alpha serine/threonine-protein kinase |
chr14 |
PF00433 |
429 |
474 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| AKT2-207 |
P31751 |
AKT2 |
RAC-beta serine/threonine-protein kinase |
chr19 |
PF00069 |
152 |
409 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| AKT2-209 |
P31751 |
AKT2 |
RAC-beta serine/threonine-protein kinase |
chr19 |
PF00069 |
152 |
409 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| AKT2-206 |
P31751 |
AKT2 |
RAC-beta serine/threonine-protein kinase |
chr19 |
PF00069 |
152 |
409 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| AKT2-212 |
P31751 |
AKT2 |
RAC-beta serine/threonine-protein kinase |
chr19 |
PF00069 |
152 |
409 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| AKT2-208 |
P31751 |
AKT2 |
RAC-beta serine/threonine-protein kinase |
chr19 |
PF00069 |
152 |
409 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| AKT2-214 |
P31751 |
AKT2 |
RAC-beta serine/threonine-protein kinase |
chr19 |
PF00069 |
152 |
409 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| AKT2-236 |
P31751 |
AKT2 |
RAC-beta serine/threonine-protein kinase |
chr19 |
PF00069 |
152 |
409 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| AKT2-219 |
P31751 |
AKT2 |
RAC-beta serine/threonine-protein kinase |
chr19 |
PF00069 |
152 |
409 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| AKT2-241 |
P31751 |
AKT2 |
RAC-beta serine/threonine-protein kinase |
chr19 |
PF00069 |
152 |
409 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| AKT2-229 |
P31751 |
AKT2 |
RAC-beta serine/threonine-protein kinase |
chr19 |
PF00069 |
152 |
409 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| AKT2-211 |
P31751 |
AKT2 |
RAC-beta serine/threonine-protein kinase |
chr19 |
PF00069 |
152 |
409 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| AKT2-205 |
P31751 |
AKT2 |
RAC-beta serine/threonine-protein kinase |
chr19 |
PF00069 |
152 |
409 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| AKT2-239 |
P31751 |
AKT2 |
RAC-beta serine/threonine-protein kinase |
chr19 |
PF00069 |
152 |
409 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| AKT2-244 |
P31751 |
AKT2 |
RAC-beta serine/threonine-protein kinase |
chr19 |
PF00069 |
152 |
409 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| AKT2-213 |
P31751 |
AKT2 |
RAC-beta serine/threonine-protein kinase |
chr19 |
PF00069 |
152 |
409 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| ANKRA2-201 |
Q9H9E1 |
ANKRA2 |
Ankyrin repeat family A protein 2 |
chr5 |
PF12796 |
134 |
243 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| ANPEP-210 |
P15144 |
ANPEP |
Aminopeptidase N |
chr15 |
PF11838 |
619 |
946 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| ANPEP-209 |
P15144 |
ANPEP |
Aminopeptidase N |
chr15 |
PF11838 |
619 |
946 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| ANPEP-205 |
P15144 |
ANPEP |
Aminopeptidase N |
chr15 |
PF11838 |
619 |
946 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| ANPEP-201 |
P15144 |
ANPEP |
Aminopeptidase N |
chr15 |
PF11838 |
619 |
946 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| AP1G2-202 |
O75843 |
AP1G2 |
AP-1 complex subunit gamma-like 2 |
chr14 |
PF02883 |
668 |
780 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| AP1G2-227 |
O75843 |
AP1G2 |
AP-1 complex subunit gamma-like 2 |
chr14 |
PF02883 |
668 |
780 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| AP1G2-231 |
O75843 |
AP1G2 |
AP-1 complex subunit gamma-like 2 |
chr14 |
PF02883 |
668 |
780 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| AP1G2-208 |
O75843 |
AP1G2 |
AP-1 complex subunit gamma-like 2 |
chr14 |
PF02883 |
668 |
780 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| AP1G2-201 |
O75843 |
AP1G2 |
AP-1 complex subunit gamma-like 2 |
chr14 |
PF02883 |
668 |
780 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| AP1G2-226 |
O75843 |
AP1G2 |
AP-1 complex subunit gamma-like 2 |
chr14 |
PF02883 |
668 |
780 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| AP2B1-210 |
P63010 |
AP2B1 |
AP-2 complex subunit beta |
chr17 |
PF02883 |
711 |
817 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| AP2B1-210 |
P63010 |
AP2B1 |
AP-2 complex subunit beta |
chr17 |
PF09066 |
827 |
935 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| AP2B1-205 |
P63010 |
AP2B1 |
AP-2 complex subunit beta |
chr17 |
PF02883 |
711 |
817 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| AP2B1-205 |
P63010 |
AP2B1 |
AP-2 complex subunit beta |
chr17 |
PF09066 |
827 |
935 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| AP2B1-211 |
P63010 |
AP2B1 |
AP-2 complex subunit beta |
chr17 |
PF02883 |
711 |
817 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| AP2B1-211 |
P63010 |
AP2B1 |
AP-2 complex subunit beta |
chr17 |
PF09066 |
827 |
935 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| AP2B1-221 |
P63010 |
AP2B1 |
AP-2 complex subunit beta |
chr17 |
PF02883 |
711 |
817 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| AP2B1-221 |
P63010 |
AP2B1 |
AP-2 complex subunit beta |
chr17 |
PF09066 |
827 |
935 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| AP2B1-216 |
P63010 |
AP2B1 |
AP-2 complex subunit beta |
chr17 |
PF02883 |
711 |
817 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| AP2B1-216 |
P63010 |
AP2B1 |
AP-2 complex subunit beta |
chr17 |
PF09066 |
827 |
935 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| AP2B1-204 |
P63010 |
AP2B1 |
AP-2 complex subunit beta |
chr17 |
PF02883 |
711 |
817 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| AP2B1-204 |
P63010 |
AP2B1 |
AP-2 complex subunit beta |
chr17 |
PF09066 |
827 |
935 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| AP2B1-217 |
P63010 |
AP2B1 |
AP-2 complex subunit beta |
chr17 |
PF02883 |
711 |
817 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| AP2B1-217 |
P63010 |
AP2B1 |
AP-2 complex subunit beta |
chr17 |
PF09066 |
827 |
935 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| AP4M1-204 |
O00189 |
AP4M1 |
AP-4 complex subunit mu-1 |
chr7 |
PF00928 |
173 |
453 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| AP4M1-211 |
O00189 |
AP4M1 |
AP-4 complex subunit mu-1 |
chr7 |
PF00928 |
173 |
453 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| AP4M1-202 |
O00189 |
AP4M1 |
AP-4 complex subunit mu-1 |
chr7 |
PF00928 |
173 |
453 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| AP4M1-201 |
O00189 |
AP4M1 |
AP-4 complex subunit mu-1 |
chr7 |
PF00928 |
173 |
453 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| AP4M1-206 |
O00189 |
AP4M1 |
AP-4 complex subunit mu-1 |
chr7 |
PF00928 |
173 |
453 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| APBB1-201 |
O00213 |
APBB1 |
Amyloid beta precursor protein binding family B member 1 |
chr11 |
PF00640 |
543 |
664 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| APBB1-220 |
O00213 |
APBB1 |
Amyloid beta precursor protein binding family B member 1 |
chr11 |
PF00640 |
543 |
664 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| APBB1-202 |
O00213 |
APBB1 |
Amyloid beta precursor protein binding family B member 1 |
chr11 |
PF00640 |
543 |
664 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| APC-203 |
P25054 |
APC |
Adenomatous polyposis coli protein |
chr5 |
PF00514 |
649 |
689 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| APC-207 |
P25054 |
APC |
Adenomatous polyposis coli protein |
chr5 |
PF00514 |
649 |
689 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| APC-202 |
P25054 |
APC |
Adenomatous polyposis coli protein |
chr5 |
PF00514 |
649 |
689 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| APC-210 |
P25054 |
APC |
Adenomatous polyposis coli protein |
chr5 |
PF00514 |
649 |
689 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| APC-209 |
P25054 |
APC |
Adenomatous polyposis coli protein |
chr5 |
PF00514 |
649 |
689 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| APC-206 |
P25054 |
APC |
Adenomatous polyposis coli protein |
chr5 |
PF00514 |
649 |
689 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| APC-201 |
P25054 |
APC |
Adenomatous polyposis coli protein |
chr5 |
PF00514 |
649 |
689 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| AR-201 |
P10275 |
AR |
Androgen receptor |
chrX |
PF00104 |
690 |
881 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| AR-203 |
P10275 |
AR |
Androgen receptor |
chrX |
PF00104 |
690 |
881 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| AR-208 |
P10275 |
AR |
Androgen receptor |
chrX |
PF00104 |
690 |
881 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| AR-206 |
P10275 |
AR |
Androgen receptor |
chrX |
PF00104 |
690 |
881 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| AR-207 |
P10275 |
AR |
Androgen receptor |
chrX |
PF00104 |
690 |
881 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| ATG12-208 |
O94817 |
ATG12 |
Ubiquitin-like protein ATG12 |
chr5 |
PF04110 |
54 |
140 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| ATG5-201 |
Q9H1Y0 |
ATG5 |
Autophagy protein 5 |
chr6 |
PF04106 |
79 |
270 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| ATG5-204 |
Q9H1Y0 |
ATG5 |
Autophagy protein 5 |
chr6 |
PF04106 |
79 |
270 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| ATG5-202 |
Q9H1Y0 |
ATG5 |
Autophagy protein 5 |
chr6 |
PF04106 |
79 |
270 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| BAIAP2-204 |
Q9UQB8 |
BAIAP2 |
Brain-specific angiogenesis inhibitor 1-associated protein 2 |
chr17 |
PF08397 |
17 |
237 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| BAIAP2-202 |
Q9UQB8 |
BAIAP2 |
Brain-specific angiogenesis inhibitor 1-associated protein 2 |
chr17 |
PF08397 |
17 |
237 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| BAIAP2-205 |
Q9UQB8 |
BAIAP2 |
Brain-specific angiogenesis inhibitor 1-associated protein 2 |
chr17 |
PF08397 |
17 |
237 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| BAIAP2-219 |
Q9UQB8 |
BAIAP2 |
Brain-specific angiogenesis inhibitor 1-associated protein 2 |
chr17 |
PF08397 |
17 |
237 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| BAIAP2-220 |
Q9UQB8 |
BAIAP2 |
Brain-specific angiogenesis inhibitor 1-associated protein 2 |
chr17 |
PF08397 |
17 |
237 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| BAIAP2-201 |
Q9UQB8 |
BAIAP2 |
Brain-specific angiogenesis inhibitor 1-associated protein 2 |
chr17 |
PF08397 |
17 |
237 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| BAIAP2-221 |
Q9UQB8 |
BAIAP2 |
Brain-specific angiogenesis inhibitor 1-associated protein 2 |
chr17 |
PF08397 |
17 |
237 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| BAX-204 |
Q07812 |
BAX |
Apoptosis regulator BAX |
chr19 |
PF00452 |
63 |
158 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| BAX-202 |
Q07812 |
BAX |
Apoptosis regulator BAX |
chr19 |
PF00452 |
63 |
158 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| BCL2A1-202 |
Q16548 |
BCL2A1 |
Bcl-2-related protein A1 |
chr15 |
PF00452 |
37 |
140 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| BCL2A1-203 |
Q16548 |
BCL2A1 |
Bcl-2-related protein A1 |
chr15 |
PF00452 |
37 |
140 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| BCL2A1-201 |
Q16548 |
BCL2A1 |
Bcl-2-related protein A1 |
chr15 |
PF00452 |
37 |
140 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| BCL2L1-206 |
Q07817 |
BCL2L1 |
Bcl-2-like protein 1 |
chr20 |
PF02180 |
1 |
26 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| BCL2L1-206 |
Q07817 |
BCL2L1 |
Bcl-2-like protein 1 |
chr20 |
PF00452 |
90 |
188 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| BCL2L1-210 |
Q07817 |
BCL2L1 |
Bcl-2-like protein 1 |
chr20 |
PF02180 |
1 |
26 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| BCL2L1-210 |
Q07817 |
BCL2L1 |
Bcl-2-like protein 1 |
chr20 |
PF00452 |
90 |
188 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| BCL2L1-215 |
Q07817 |
BCL2L1 |
Bcl-2-like protein 1 |
chr20 |
PF02180 |
1 |
26 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| BCL2L1-215 |
Q07817 |
BCL2L1 |
Bcl-2-like protein 1 |
chr20 |
PF00452 |
90 |
188 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| BCL2L1-204 |
Q07817 |
BCL2L1 |
Bcl-2-like protein 1 |
chr20 |
PF02180 |
1 |
26 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| BCL2L1-204 |
Q07817 |
BCL2L1 |
Bcl-2-like protein 1 |
chr20 |
PF00452 |
90 |
188 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| BCL2L1-209 |
Q07817 |
BCL2L1 |
Bcl-2-like protein 1 |
chr20 |
PF02180 |
1 |
26 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| BCL2L1-209 |
Q07817 |
BCL2L1 |
Bcl-2-like protein 1 |
chr20 |
PF00452 |
90 |
188 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| BCL2L1-211 |
Q07817 |
BCL2L1 |
Bcl-2-like protein 1 |
chr20 |
PF02180 |
1 |
26 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| BCL2L1-211 |
Q07817 |
BCL2L1 |
Bcl-2-like protein 1 |
chr20 |
PF00452 |
90 |
188 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| BCL2L1-214 |
Q07817 |
BCL2L1 |
Bcl-2-like protein 1 |
chr20 |
PF02180 |
1 |
26 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| BCL2L1-214 |
Q07817 |
BCL2L1 |
Bcl-2-like protein 1 |
chr20 |
PF00452 |
90 |
188 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| BCL2L1-205 |
Q07817 |
BCL2L1 |
Bcl-2-like protein 1 |
chr20 |
PF02180 |
1 |
26 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| BCL2L1-205 |
Q07817 |
BCL2L1 |
Bcl-2-like protein 1 |
chr20 |
PF00452 |
90 |
188 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| BCL2L1-207 |
Q07817 |
BCL2L1 |
Bcl-2-like protein 1 |
chr20 |
PF02180 |
1 |
26 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| BCL2L1-207 |
Q07817 |
BCL2L1 |
Bcl-2-like protein 1 |
chr20 |
PF00452 |
90 |
188 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| BCL2L1-201 |
Q07817 |
BCL2L1 |
Bcl-2-like protein 1 |
chr20 |
PF02180 |
1 |
26 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| BCL2L1-201 |
Q07817 |
BCL2L1 |
Bcl-2-like protein 1 |
chr20 |
PF00452 |
90 |
188 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| BCL2L1-202 |
Q07817 |
BCL2L1 |
Bcl-2-like protein 1 |
chr20 |
PF02180 |
1 |
26 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| BCL2L1-202 |
Q07817 |
BCL2L1 |
Bcl-2-like protein 1 |
chr20 |
PF00452 |
90 |
188 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| BCL2L1-203 |
Q07817 |
BCL2L1 |
Bcl-2-like protein 1 |
chr20 |
PF02180 |
1 |
26 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| BCL2L1-203 |
Q07817 |
BCL2L1 |
Bcl-2-like protein 1 |
chr20 |
PF00452 |
90 |
188 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| BCL2L1-212 |
Q07817 |
BCL2L1 |
Bcl-2-like protein 1 |
chr20 |
PF02180 |
1 |
26 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| BCL2L1-212 |
Q07817 |
BCL2L1 |
Bcl-2-like protein 1 |
chr20 |
PF00452 |
90 |
188 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| BCL2L1-208 |
Q07817 |
BCL2L1 |
Bcl-2-like protein 1 |
chr20 |
PF02180 |
1 |
26 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| BCL2L1-208 |
Q07817 |
BCL2L1 |
Bcl-2-like protein 1 |
chr20 |
PF00452 |
90 |
188 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| BCL2L2-209 |
Q92843 |
BCL2L2 |
Bcl-2-like protein 2 |
chr14 |
PF02180 |
6 |
31 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| BCL2L2-204 |
Q92843 |
BCL2L2 |
Bcl-2-like protein 2 |
chr14 |
PF02180 |
6 |
31 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| BCL2L2-206 |
Q92843 |
BCL2L2 |
Bcl-2-like protein 2 |
chr14 |
PF02180 |
6 |
31 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| BCL2L2-203 |
Q92843 |
BCL2L2 |
Bcl-2-like protein 2 |
chr14 |
PF02180 |
6 |
31 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| BCL2L2-210 |
Q92843 |
BCL2L2 |
Bcl-2-like protein 2 |
chr14 |
PF02180 |
6 |
31 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| BCL2L2-207 |
Q92843 |
BCL2L2 |
Bcl-2-like protein 2 |
chr14 |
PF02180 |
6 |
31 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| BCL2L2-208 |
Q92843 |
BCL2L2 |
Bcl-2-like protein 2 |
chr14 |
PF02180 |
6 |
31 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| BCL2L2-201 |
Q92843 |
BCL2L2 |
Bcl-2-like protein 2 |
chr14 |
PF02180 |
6 |
31 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| BCL2L2-202 |
Q92843 |
BCL2L2 |
Bcl-2-like protein 2 |
chr14 |
PF02180 |
6 |
31 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| BCL2L2-PABPN1-203 |
Q92843 |
BCL2L2 |
Bcl-2-like protein 2 |
chr14 |
PF02180 |
6 |
31 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| BCL6-202 |
P41182 |
BCL6 |
B-cell lymphoma 6 protein |
chr3 |
PF00651 |
22 |
129 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| BCL6-201 |
P41182 |
BCL6 |
B-cell lymphoma 6 protein |
chr3 |
PF00651 |
22 |
129 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| BCL6-204 |
P41182 |
BCL6 |
B-cell lymphoma 6 protein |
chr3 |
PF00651 |
22 |
129 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| BIRC2-208 |
Q13490 |
BIRC2 |
Baculoviral IAP repeat-containing protein 2 |
chr11 |
PF00653 |
272 |
337 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| BIRC2-206 |
Q13490 |
BIRC2 |
Baculoviral IAP repeat-containing protein 2 |
chr11 |
PF00653 |
272 |
337 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| BIRC2-201 |
Q13490 |
BIRC2 |
Baculoviral IAP repeat-containing protein 2 |
chr11 |
PF00653 |
272 |
337 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| BIRC2-213 |
Q13490 |
BIRC2 |
Baculoviral IAP repeat-containing protein 2 |
chr11 |
PF00653 |
272 |
337 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| BIRC5-202 |
O15392 |
BIRC5 |
Baculoviral IAP repeat-containing protein 5 |
chr17 |
PF00653 |
18 |
88 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| C3-201 |
P01024 |
C3 |
Complement C3 |
chr19 |
PF01835 |
129 |
224 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| C3-228 |
P01024 |
C3 |
Complement C3 |
chr19 |
PF01835 |
129 |
224 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| C8G-201 |
P07360 |
C8G |
Complement component C8 gamma chain |
chr9 |
PF00061 |
48 |
186 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CASP7-206 |
P55210 |
CASP7 |
Caspase-7 |
chr10 |
PF00656 |
68 |
301 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CASP7-211 |
P55210 |
CASP7 |
Caspase-7 |
chr10 |
PF00656 |
68 |
301 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CASP7-212 |
P55210 |
CASP7 |
Caspase-7 |
chr10 |
PF00656 |
68 |
301 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CASP7-202 |
P55210 |
CASP7 |
Caspase-7 |
chr10 |
PF00656 |
68 |
301 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CASP7-203 |
P55210 |
CASP7 |
Caspase-7 |
chr10 |
PF00656 |
68 |
301 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CASP7-201 |
P55210 |
CASP7 |
Caspase-7 |
chr10 |
PF00656 |
68 |
301 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CBX1-202 |
P83916 |
CBX1 |
Chromobox protein homolog 1 |
chr17 |
PF01393 |
118 |
170 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CBX1-204 |
P83916 |
CBX1 |
Chromobox protein homolog 1 |
chr17 |
PF01393 |
118 |
170 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CBX1-206 |
P83916 |
CBX1 |
Chromobox protein homolog 1 |
chr17 |
PF01393 |
118 |
170 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CBX1-205 |
P83916 |
CBX1 |
Chromobox protein homolog 1 |
chr17 |
PF01393 |
118 |
170 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CBX1-201 |
P83916 |
CBX1 |
Chromobox protein homolog 1 |
chr17 |
PF01393 |
118 |
170 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CBX3-201 |
Q13185 |
CBX3 |
Chromobox protein homolog 3 |
chr7 |
PF00385 |
30 |
79 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CBX3-202 |
Q13185 |
CBX3 |
Chromobox protein homolog 3 |
chr7 |
PF00385 |
30 |
79 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CBX3-204 |
Q13185 |
CBX3 |
Chromobox protein homolog 3 |
chr7 |
PF00385 |
30 |
79 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CCNA2-201 |
P20248 |
CCNA2 |
Cyclin-A2 |
chr4 |
PF02984 |
309 |
427 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CCNA2-201 |
P20248 |
CCNA2 |
Cyclin-A2 |
chr4 |
PF00134 |
181 |
307 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CCNT1-202 |
O60563 |
CCNT1 |
Cyclin-T1 |
chr12 |
PF00134 |
10 |
149 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CCNT1-205 |
O60563 |
CCNT1 |
Cyclin-T1 |
chr12 |
PF00134 |
10 |
149 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CCNT1-201 |
O60563 |
CCNT1 |
Cyclin-T1 |
chr12 |
PF00134 |
10 |
149 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CDC20-202 |
Q12834 |
CDC20 |
Cell division cycle protein 20 homolog |
chr1 |
PF12894 |
218 |
279 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CDC20-201 |
Q12834 |
CDC20 |
Cell division cycle protein 20 homolog |
chr1 |
PF12894 |
218 |
279 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CDK2-208 |
P24941 |
CDK2 |
Cyclin-dependent kinase 2 |
chr12 |
PF00069 |
4 |
286 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CDK2-207 |
P24941 |
CDK2 |
Cyclin-dependent kinase 2 |
chr12 |
PF00069 |
4 |
286 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CDK2-201 |
P24941 |
CDK2 |
Cyclin-dependent kinase 2 |
chr12 |
PF00069 |
4 |
286 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CEP55-201 |
Q53EZ4 |
CEP55 |
Centrosomal protein of 55 kDa |
chr10 |
PF12180 |
171 |
204 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CETN2-201 |
P41208 |
CETN2 |
Centrin-2 |
chrX |
PF13499 |
103 |
167 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CHEK1-213 |
O14757 |
CHEK1 |
Serine/threonine-protein kinase Chk1 |
chr11 |
PF00069 |
9 |
265 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CHEK1-211 |
O14757 |
CHEK1 |
Serine/threonine-protein kinase Chk1 |
chr11 |
PF00069 |
9 |
265 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CHEK1-207 |
O14757 |
CHEK1 |
Serine/threonine-protein kinase Chk1 |
chr11 |
PF00069 |
9 |
265 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CHEK1-208 |
O14757 |
CHEK1 |
Serine/threonine-protein kinase Chk1 |
chr11 |
PF00069 |
9 |
265 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CHEK1-203 |
O14757 |
CHEK1 |
Serine/threonine-protein kinase Chk1 |
chr11 |
PF00069 |
9 |
265 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CHEK1-205 |
O14757 |
CHEK1 |
Serine/threonine-protein kinase Chk1 |
chr11 |
PF00069 |
9 |
265 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CHEK1-214 |
O14757 |
CHEK1 |
Serine/threonine-protein kinase Chk1 |
chr11 |
PF00069 |
9 |
265 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CHEK1-204 |
O14757 |
CHEK1 |
Serine/threonine-protein kinase Chk1 |
chr11 |
PF00069 |
9 |
265 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CLIP1-219 |
P30622 |
CLIP1 |
CAP-Gly domain-containing linker protein 1 |
chr12 |
PF01302 |
214 |
278 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CLIP1-212 |
P30622 |
CLIP1 |
CAP-Gly domain-containing linker protein 1 |
chr12 |
PF01302 |
214 |
278 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CLIP1-202 |
P30622 |
CLIP1 |
CAP-Gly domain-containing linker protein 1 |
chr12 |
PF01302 |
214 |
278 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CLIP1-201 |
P30622 |
CLIP1 |
CAP-Gly domain-containing linker protein 1 |
chr12 |
PF01302 |
214 |
278 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CREBBP-202 |
Q92793 |
CREBBP |
CREB-binding protein |
chr16 |
PF00439 |
1094 |
1180 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CREBBP-201 |
Q92793 |
CREBBP |
CREB-binding protein |
chr16 |
PF00439 |
1094 |
1180 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CTNNB1-234 |
P35222 |
CTNNB1 |
Catenin beta-1 |
chr3 |
PF00514 |
583 |
623 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CTNNB1-222 |
P35222 |
CTNNB1 |
Catenin beta-1 |
chr3 |
PF00514 |
583 |
623 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CTNNB1-219 |
P35222 |
CTNNB1 |
Catenin beta-1 |
chr3 |
PF00514 |
583 |
623 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CTNNB1-206 |
P35222 |
CTNNB1 |
Catenin beta-1 |
chr3 |
PF00514 |
583 |
623 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CTNNB1-238 |
P35222 |
CTNNB1 |
Catenin beta-1 |
chr3 |
PF00514 |
583 |
623 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CTNNB1-251 |
P35222 |
CTNNB1 |
Catenin beta-1 |
chr3 |
PF00514 |
583 |
623 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CTNNB1-216 |
P35222 |
CTNNB1 |
Catenin beta-1 |
chr3 |
PF00514 |
583 |
623 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CTNNB1-207 |
P35222 |
CTNNB1 |
Catenin beta-1 |
chr3 |
PF00514 |
583 |
623 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CTNNB1-203 |
P35222 |
CTNNB1 |
Catenin beta-1 |
chr3 |
PF00514 |
583 |
623 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CTNNB1-204 |
P35222 |
CTNNB1 |
Catenin beta-1 |
chr3 |
PF00514 |
583 |
623 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CTNNB1-242 |
P35222 |
CTNNB1 |
Catenin beta-1 |
chr3 |
PF00514 |
583 |
623 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CTNNB1-223 |
P35222 |
CTNNB1 |
Catenin beta-1 |
chr3 |
PF00514 |
583 |
623 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CTNNB1-235 |
P35222 |
CTNNB1 |
Catenin beta-1 |
chr3 |
PF00514 |
583 |
623 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CTNNB1-236 |
P35222 |
CTNNB1 |
Catenin beta-1 |
chr3 |
PF00514 |
583 |
623 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CTNNB1-250 |
P35222 |
CTNNB1 |
Catenin beta-1 |
chr3 |
PF00514 |
583 |
623 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CTNNB1-256 |
P35222 |
CTNNB1 |
Catenin beta-1 |
chr3 |
PF00514 |
583 |
623 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CTNNB1-248 |
P35222 |
CTNNB1 |
Catenin beta-1 |
chr3 |
PF00514 |
583 |
623 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CTNNB1-226 |
P35222 |
CTNNB1 |
Catenin beta-1 |
chr3 |
PF00514 |
583 |
623 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CTNNB1-228 |
P35222 |
CTNNB1 |
Catenin beta-1 |
chr3 |
PF00514 |
583 |
623 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CTNNB1-233 |
P35222 |
CTNNB1 |
Catenin beta-1 |
chr3 |
PF00514 |
583 |
623 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CTNNB1-225 |
P35222 |
CTNNB1 |
Catenin beta-1 |
chr3 |
PF00514 |
583 |
623 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CTNNB1-209 |
P35222 |
CTNNB1 |
Catenin beta-1 |
chr3 |
PF00514 |
583 |
623 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CTNNB1-217 |
P35222 |
CTNNB1 |
Catenin beta-1 |
chr3 |
PF00514 |
583 |
623 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CTNNB1-241 |
P35222 |
CTNNB1 |
Catenin beta-1 |
chr3 |
PF00514 |
583 |
623 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CTNNB1-208 |
P35222 |
CTNNB1 |
Catenin beta-1 |
chr3 |
PF00514 |
583 |
623 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CTNNB1-201 |
P35222 |
CTNNB1 |
Catenin beta-1 |
chr3 |
PF00514 |
583 |
623 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CTNNB1-218 |
P35222 |
CTNNB1 |
Catenin beta-1 |
chr3 |
PF00514 |
583 |
623 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CTNNB1-247 |
P35222 |
CTNNB1 |
Catenin beta-1 |
chr3 |
PF00514 |
583 |
623 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CTNNB1-252 |
P35222 |
CTNNB1 |
Catenin beta-1 |
chr3 |
PF00514 |
583 |
623 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CTNNB1-230 |
P35222 |
CTNNB1 |
Catenin beta-1 |
chr3 |
PF00514 |
583 |
623 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CTNNB1-255 |
P35222 |
CTNNB1 |
Catenin beta-1 |
chr3 |
PF00514 |
583 |
623 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CTNNB1-229 |
P35222 |
CTNNB1 |
Catenin beta-1 |
chr3 |
PF00514 |
583 |
623 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CTNNB1-249 |
P35222 |
CTNNB1 |
Catenin beta-1 |
chr3 |
PF00514 |
583 |
623 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CTNNB1-244 |
P35222 |
CTNNB1 |
Catenin beta-1 |
chr3 |
PF00514 |
583 |
623 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CTNNB1-254 |
P35222 |
CTNNB1 |
Catenin beta-1 |
chr3 |
PF00514 |
583 |
623 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CTNNB1-210 |
P35222 |
CTNNB1 |
Catenin beta-1 |
chr3 |
PF00514 |
583 |
623 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CTNNB1-246 |
P35222 |
CTNNB1 |
Catenin beta-1 |
chr3 |
PF00514 |
583 |
623 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CTNNB1-202 |
P35222 |
CTNNB1 |
Catenin beta-1 |
chr3 |
PF00514 |
583 |
623 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CTNNB1-239 |
P35222 |
CTNNB1 |
Catenin beta-1 |
chr3 |
PF00514 |
583 |
623 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CTNND1-201 |
O60716 |
CTNND1 |
Catenin delta-1 |
chr11 |
PF00514 |
701 |
739 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CTNND1-241 |
O60716 |
CTNND1 |
Catenin delta-1 |
chr11 |
PF00514 |
701 |
739 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CTNND1-214 |
O60716 |
CTNND1 |
Catenin delta-1 |
chr11 |
PF00514 |
701 |
739 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CTNND1-205 |
O60716 |
CTNND1 |
Catenin delta-1 |
chr11 |
PF00514 |
701 |
739 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CTNND1-203 |
O60716 |
CTNND1 |
Catenin delta-1 |
chr11 |
PF00514 |
701 |
739 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CTNND1-208 |
O60716 |
CTNND1 |
Catenin delta-1 |
chr11 |
PF00514 |
701 |
739 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CTNND1-212 |
O60716 |
CTNND1 |
Catenin delta-1 |
chr11 |
PF00514 |
701 |
739 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CTNND1-202 |
O60716 |
CTNND1 |
Catenin delta-1 |
chr11 |
PF00514 |
701 |
739 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CTNND1-204 |
O60716 |
CTNND1 |
Catenin delta-1 |
chr11 |
PF00514 |
701 |
739 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CTNND1-218 |
O60716 |
CTNND1 |
Catenin delta-1 |
chr11 |
PF00514 |
701 |
739 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CTNND1-219 |
O60716 |
CTNND1 |
Catenin delta-1 |
chr11 |
PF00514 |
701 |
739 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CTNND1-220 |
O60716 |
CTNND1 |
Catenin delta-1 |
chr11 |
PF00514 |
701 |
739 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CTNND1-226 |
O60716 |
CTNND1 |
Catenin delta-1 |
chr11 |
PF00514 |
701 |
739 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CTNND1-227 |
O60716 |
CTNND1 |
Catenin delta-1 |
chr11 |
PF00514 |
701 |
739 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CTNND1-231 |
O60716 |
CTNND1 |
Catenin delta-1 |
chr11 |
PF00514 |
701 |
739 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CTNND1-239 |
O60716 |
CTNND1 |
Catenin delta-1 |
chr11 |
PF00514 |
701 |
739 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CTNND1-233 |
O60716 |
CTNND1 |
Catenin delta-1 |
chr11 |
PF00514 |
701 |
739 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CTNND1-236 |
O60716 |
CTNND1 |
Catenin delta-1 |
chr11 |
PF00514 |
701 |
739 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CTNND1-238 |
O60716 |
CTNND1 |
Catenin delta-1 |
chr11 |
PF00514 |
701 |
739 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CTNND1-209 |
O60716 |
CTNND1 |
Catenin delta-1 |
chr11 |
PF00514 |
701 |
739 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CTNND1-221 |
O60716 |
CTNND1 |
Catenin delta-1 |
chr11 |
PF00514 |
701 |
739 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| CTTN-201 |
Q14247 |
CTTN |
Src substrate cortactin |
chr11 |
PF14604 |
499 |
547 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| DCTN1-228 |
Q14203 |
DCTN1 |
Dynactin subunit 1 |
chr2 |
PF01302 |
29 |
94 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| DCTN1-206 |
Q14203 |
DCTN1 |
Dynactin subunit 1 |
chr2 |
PF01302 |
29 |
94 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| DCTN1-226 |
Q14203 |
DCTN1 |
Dynactin subunit 1 |
chr2 |
PF01302 |
29 |
94 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| DCTN1-202 |
Q14203 |
DCTN1 |
Dynactin subunit 1 |
chr2 |
PF01302 |
29 |
94 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| DCTN1-205 |
Q14203 |
DCTN1 |
Dynactin subunit 1 |
chr2 |
PF01302 |
29 |
94 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| DCTN1-201 |
Q14203 |
DCTN1 |
Dynactin subunit 1 |
chr2 |
PF01302 |
29 |
94 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| DCTN1-203 |
Q14203 |
DCTN1 |
Dynactin subunit 1 |
chr2 |
PF01302 |
29 |
94 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| DCUN1D3-201 |
Q8IWE4 |
DCUN1D3 |
DCN1-like protein 3 |
chr16 |
PF03556 |
162 |
276 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| DCUN1D3-202 |
Q8IWE4 |
DCUN1D3 |
DCN1-like protein 3 |
chr16 |
PF03556 |
162 |
276 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| DDX6-206 |
P26196 |
DDX6 |
Probable ATP-dependent RNA helicase DDX6 |
chr11 |
PF00271 |
320 |
429 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| DDX6-202 |
P26196 |
DDX6 |
Probable ATP-dependent RNA helicase DDX6 |
chr11 |
PF00271 |
320 |
429 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| DDX6-207 |
P26196 |
DDX6 |
Probable ATP-dependent RNA helicase DDX6 |
chr11 |
PF00271 |
320 |
429 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| DLG1-269 |
Q12959 |
DLG1 |
Disks large homolog 1 |
chr3 |
PF00595 |
466 |
544 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| DLG1-206 |
Q12959 |
DLG1 |
Disks large homolog 1 |
chr3 |
PF00595 |
466 |
544 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| DLG1-203 |
Q12959 |
DLG1 |
Disks large homolog 1 |
chr3 |
PF00595 |
466 |
544 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| DLG1-204 |
Q12959 |
DLG1 |
Disks large homolog 1 |
chr3 |
PF00595 |
466 |
544 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| DLG1-215 |
Q12959 |
DLG1 |
Disks large homolog 1 |
chr3 |
PF00595 |
466 |
544 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| DLG1-212 |
Q12959 |
DLG1 |
Disks large homolog 1 |
chr3 |
PF00595 |
466 |
544 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| DLG1-208 |
Q12959 |
DLG1 |
Disks large homolog 1 |
chr3 |
PF00595 |
466 |
544 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| DLG1-201 |
Q12959 |
DLG1 |
Disks large homolog 1 |
chr3 |
PF00595 |
466 |
544 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| DLG1-247 |
Q12959 |
DLG1 |
Disks large homolog 1 |
chr3 |
PF00595 |
466 |
544 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| DNAJB1-201 |
P25685 |
DNAJB1 |
DnaJ homolog subfamily B member 1 |
chr19 |
PF01556 |
164 |
323 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| DNMBP-201 |
Q6XZF7 |
DNMBP |
Dynamin-binding protein |
chr10 |
PF00018 |
1519 |
1568 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| DPP3-207 |
Q9NY33 |
DPP3 |
Dipeptidyl peptidase 3 |
chr11 |
PF03571 |
143 |
704 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| DPP3-208 |
Q9NY33 |
DPP3 |
Dipeptidyl peptidase 3 |
chr11 |
PF03571 |
143 |
704 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| DPP3-209 |
Q9NY33 |
DPP3 |
Dipeptidyl peptidase 3 |
chr11 |
PF03571 |
143 |
704 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| DPP3-215 |
Q9NY33 |
DPP3 |
Dipeptidyl peptidase 3 |
chr11 |
PF03571 |
143 |
704 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| DPP3-211 |
Q9NY33 |
DPP3 |
Dipeptidyl peptidase 3 |
chr11 |
PF03571 |
143 |
704 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| DPP4-214 |
P27487 |
DPP4 |
Dipeptidyl peptidase 4 |
chr2 |
PF00326 |
559 |
765 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| DPP4-201 |
P27487 |
DPP4 |
Dipeptidyl peptidase 4 |
chr2 |
PF00326 |
559 |
765 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| DPP4-219 |
P27487 |
DPP4 |
Dipeptidyl peptidase 4 |
chr2 |
PF00326 |
559 |
765 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| DPP4-213 |
P27487 |
DPP4 |
Dipeptidyl peptidase 4 |
chr2 |
PF00326 |
559 |
765 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| DPY30-202 |
Q9C005 |
DPY30 |
Protein dpy-30 homolog |
chr2 |
PF05186 |
52 |
93 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| DPY30-201 |
Q9C005 |
DPY30 |
Protein dpy-30 homolog |
chr2 |
PF05186 |
52 |
93 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| DYNLL1-203 |
P63167 |
DYNLL1 |
Dynein light chain 1, cytoplasmic |
chr12 |
PF01221 |
5 |
88 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| DYNLL1-205 |
P63167 |
DYNLL1 |
Dynein light chain 1, cytoplasmic |
chr12 |
PF01221 |
5 |
88 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| DYNLL1-202 |
P63167 |
DYNLL1 |
Dynein light chain 1, cytoplasmic |
chr12 |
PF01221 |
5 |
88 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| DYNLL1-207 |
P63167 |
DYNLL1 |
Dynein light chain 1, cytoplasmic |
chr12 |
PF01221 |
5 |
88 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| DYNLL1-201 |
P63167 |
DYNLL1 |
Dynein light chain 1, cytoplasmic |
chr12 |
PF01221 |
5 |
88 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| DYNLL2-201 |
Q96FJ2 |
DYNLL2 |
Dynein light chain 2, cytoplasmic |
chr17 |
PF01221 |
5 |
88 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| EGFR-205 |
P00533 |
EGFR |
Epidermal growth factor receptor |
chr7 |
PF01030 |
361 |
481 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| EGFR-205 |
P00533 |
EGFR |
Epidermal growth factor receptor |
chr7 |
PF00757 |
177 |
338 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| EGFR-202 |
P00533 |
EGFR |
Epidermal growth factor receptor |
chr7 |
PF01030 |
361 |
481 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| EGFR-202 |
P00533 |
EGFR |
Epidermal growth factor receptor |
chr7 |
PF00757 |
177 |
338 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| EGFR-201 |
P00533 |
EGFR |
Epidermal growth factor receptor |
chr7 |
PF01030 |
361 |
481 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| EGFR-201 |
P00533 |
EGFR |
Epidermal growth factor receptor |
chr7 |
PF00757 |
177 |
338 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| EGLN1-201 |
Q9GZT9 |
EGLN1 |
Egl nine homolog 1 |
chr1 |
PF13640 |
298 |
391 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| EIF4E-203 |
P06730 |
EIF4E |
Eukaryotic translation initiation factor 4E |
chr4 |
PF01652 |
38 |
197 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| ENST00000558468 |
Q96EP0 |
RNF31 |
E3 ubiquitin-protein ligase RNF31 |
chr14 |
PF09409 |
69 |
150 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| ENST00000650585 |
O00522 |
KRIT1 |
Krev interaction trapped protein 1 |
chr7 |
PF00373 |
517 |
640 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| ENST00000691972 |
O00522 |
KRIT1 |
Krev interaction trapped protein 1 |
chr7 |
PF00373 |
517 |
640 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| ENST00000458493 |
O00522 |
KRIT1 |
Krev interaction trapped protein 1 |
chr7 |
PF00373 |
517 |
640 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| ENST00000692281 |
O00522 |
KRIT1 |
Krev interaction trapped protein 1 |
chr7 |
PF00373 |
517 |
640 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| EPB41L3-212 |
Q9Y2J2 |
EPB41L3 |
Band 4.1-like protein 3 |
chr18 |
PF09379 |
114 |
177 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| EPB41L3-233 |
Q9Y2J2 |
EPB41L3 |
Band 4.1-like protein 3 |
chr18 |
PF09379 |
114 |
177 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| EPB41L3-201 |
Q9Y2J2 |
EPB41L3 |
Band 4.1-like protein 3 |
chr18 |
PF09379 |
114 |
177 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| EPHA4-201 |
P54764 |
EPHA4 |
Ephrin type-A receptor 4 |
chr2 |
PF01404 |
31 |
204 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| EPHA4-214 |
P54764 |
EPHA4 |
Ephrin type-A receptor 4 |
chr2 |
PF01404 |
31 |
204 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| EPHA4-203 |
P54764 |
EPHA4 |
Ephrin type-A receptor 4 |
chr2 |
PF01404 |
31 |
204 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| EPHA4-202 |
P54764 |
EPHA4 |
Ephrin type-A receptor 4 |
chr2 |
PF01404 |
31 |
204 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| EPHA4-207 |
P54764 |
EPHA4 |
Ephrin type-A receptor 4 |
chr2 |
PF01404 |
31 |
204 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| ERAP2-206 |
Q6P179 |
ERAP2 |
Endoplasmic reticulum aminopeptidase 2 |
chr5 |
PF01433 |
298 |
541 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| ERAP2-202 |
Q6P179 |
ERAP2 |
Endoplasmic reticulum aminopeptidase 2 |
chr5 |
PF01433 |
298 |
541 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| ERBIN-201 |
Q96RT1 |
ERBIN |
Erbin |
chr5 |
PF00595 |
1321 |
1407 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| ERBIN-204 |
Q96RT1 |
ERBIN |
Erbin |
chr5 |
PF00595 |
1321 |
1407 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| ERBIN-205 |
Q96RT1 |
ERBIN |
Erbin |
chr5 |
PF00595 |
1321 |
1407 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| ERBIN-207 |
Q96RT1 |
ERBIN |
Erbin |
chr5 |
PF00595 |
1321 |
1407 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| ERBIN-214 |
Q96RT1 |
ERBIN |
Erbin |
chr5 |
PF00595 |
1321 |
1407 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| ERBIN-221 |
Q96RT1 |
ERBIN |
Erbin |
chr5 |
PF00595 |
1321 |
1407 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| ERBIN-223 |
Q96RT1 |
ERBIN |
Erbin |
chr5 |
PF00595 |
1321 |
1407 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| ESR1-210 |
P03372 |
ESR1 |
Estrogen receptor |
chr6 |
PF00104 |
332 |
531 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| ESR1-201 |
P03372 |
ESR1 |
Estrogen receptor |
chr6 |
PF00104 |
332 |
531 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| ESR1-204 |
P03372 |
ESR1 |
Estrogen receptor |
chr6 |
PF00104 |
332 |
531 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| ESR1-208 |
P03372 |
ESR1 |
Estrogen receptor |
chr6 |
PF00104 |
332 |
531 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| ESR1-209 |
P03372 |
ESR1 |
Estrogen receptor |
chr6 |
PF00104 |
332 |
531 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| ESR1-202 |
P03372 |
ESR1 |
Estrogen receptor |
chr6 |
PF00104 |
332 |
531 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| ESR1-207 |
P03372 |
ESR1 |
Estrogen receptor |
chr6 |
PF00104 |
332 |
531 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| ESR1-203 |
P03372 |
ESR1 |
Estrogen receptor |
chr6 |
PF00104 |
332 |
531 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| ESR2-206 |
Q92731 |
ESR2 |
Estrogen receptor beta |
chr14 |
PF00104 |
283 |
482 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| ESR2-202 |
Q92731 |
ESR2 |
Estrogen receptor beta |
chr14 |
PF00104 |
283 |
482 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| ESR2-213 |
Q92731 |
ESR2 |
Estrogen receptor beta |
chr14 |
PF00104 |
283 |
482 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| ESRRA-202 |
P11474 |
ESRRA |
Steroid hormone receptor ERR1 |
chr11 |
PF00104 |
224 |
404 |
Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| ESRRA-201 |
P11474 |
ESRRA |
Steroid hormone receptor ERR1 |
chr11 |
PF00104 |
224 |
404 |
Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| ESRRA-205 |
P11474 |
ESRRA |
Steroid hormone receptor ERR1 |
chr11 |
PF00104 |
224 |
404 |
Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| ESRRA-208 |
P11474 |
ESRRA |
Steroid hormone receptor ERR1 |
chr11 |
PF00104 |
224 |
404 |
Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| ESRRG-224 |
P62508 |
ESRRG |
Estrogen-related receptor gamma |
chr1 |
PF00104 |
255 |
441 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| ESRRG-206 |
P62508 |
ESRRG |
Estrogen-related receptor gamma |
chr1 |
PF00104 |
255 |
441 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| ESRRG-225 |
P62508 |
ESRRG |
Estrogen-related receptor gamma |
chr1 |
PF00104 |
255 |
441 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| ESRRG-219 |
P62508 |
ESRRG |
Estrogen-related receptor gamma |
chr1 |
PF00104 |
255 |
441 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| ESRRG-222 |
P62508 |
ESRRG |
Estrogen-related receptor gamma |
chr1 |
PF00104 |
255 |
441 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| ESRRG-201 |
P62508 |
ESRRG |
Estrogen-related receptor gamma |
chr1 |
PF00104 |
255 |
441 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| ESRRG-203 |
P62508 |
ESRRG |
Estrogen-related receptor gamma |
chr1 |
PF00104 |
255 |
441 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| ESRRG-202 |
P62508 |
ESRRG |
Estrogen-related receptor gamma |
chr1 |
PF00104 |
255 |
441 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| ESRRG-221 |
P62508 |
ESRRG |
Estrogen-related receptor gamma |
chr1 |
PF00104 |
255 |
441 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| ESRRG-207 |
P62508 |
ESRRG |
Estrogen-related receptor gamma |
chr1 |
PF00104 |
255 |
441 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| ESRRG-209 |
P62508 |
ESRRG |
Estrogen-related receptor gamma |
chr1 |
PF00104 |
255 |
441 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| ESRRG-204 |
P62508 |
ESRRG |
Estrogen-related receptor gamma |
chr1 |
PF00104 |
255 |
441 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| ESRRG-208 |
P62508 |
ESRRG |
Estrogen-related receptor gamma |
chr1 |
PF00104 |
255 |
441 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| ESRRG-205 |
P62508 |
ESRRG |
Estrogen-related receptor gamma |
chr1 |
PF00104 |
255 |
441 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| F11-202 |
P03951 |
F11 |
Coagulation factor XI |
chr4 |
PF00089 |
388 |
618 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| F11-204 |
P03951 |
F11 |
Coagulation factor XI |
chr4 |
PF00089 |
388 |
618 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| F2-201 |
P00734 |
F2 |
Prothrombin |
chr11 |
PF00089 |
364 |
613 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| FLNA-202 |
P21333 |
FLNA |
Filamin-A |
chrX |
PF00630 |
2554 |
2643 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| FLNA-220 |
P21333 |
FLNA |
Filamin-A |
chrX |
PF00630 |
2554 |
2643 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| FLNA-203 |
P21333 |
FLNA |
Filamin-A |
chrX |
PF00630 |
2554 |
2643 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| FLNA-201 |
P21333 |
FLNA |
Filamin-A |
chrX |
PF00630 |
2554 |
2643 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| FN1-208 |
P02751 |
FN1 |
Fibronectin |
chr2 |
PF00039 |
2386 |
2421 |
Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| FN1-201 |
P02751 |
FN1 |
Fibronectin |
chr2 |
PF00039 |
2386 |
2421 |
Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| FN1-203 |
P02751 |
FN1 |
Fibronectin |
chr2 |
PF00039 |
2386 |
2421 |
Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| FYN-222 |
P06241 |
FYN |
Tyrosine-protein kinase Fyn |
chr6 |
PF00018 |
88 |
135 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| FYN-212 |
P06241 |
FYN |
Tyrosine-protein kinase Fyn |
chr6 |
PF00018 |
88 |
135 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| FYN-203 |
P06241 |
FYN |
Tyrosine-protein kinase Fyn |
chr6 |
PF00018 |
88 |
135 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| FYN-207 |
P06241 |
FYN |
Tyrosine-protein kinase Fyn |
chr6 |
PF00018 |
88 |
135 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| FYN-226 |
P06241 |
FYN |
Tyrosine-protein kinase Fyn |
chr6 |
PF00018 |
88 |
135 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| FYN-227 |
P06241 |
FYN |
Tyrosine-protein kinase Fyn |
chr6 |
PF00018 |
88 |
135 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| FYN-228 |
P06241 |
FYN |
Tyrosine-protein kinase Fyn |
chr6 |
PF00018 |
88 |
135 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| FYN-219 |
P06241 |
FYN |
Tyrosine-protein kinase Fyn |
chr6 |
PF00018 |
88 |
135 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| FYN-202 |
P06241 |
FYN |
Tyrosine-protein kinase Fyn |
chr6 |
PF00018 |
88 |
135 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| FYN-221 |
P06241 |
FYN |
Tyrosine-protein kinase Fyn |
chr6 |
PF00018 |
88 |
135 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| FYN-218 |
P06241 |
FYN |
Tyrosine-protein kinase Fyn |
chr6 |
PF00018 |
88 |
135 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| FYN-220 |
P06241 |
FYN |
Tyrosine-protein kinase Fyn |
chr6 |
PF00018 |
88 |
135 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| FYN-224 |
P06241 |
FYN |
Tyrosine-protein kinase Fyn |
chr6 |
PF00018 |
88 |
135 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| FYN-206 |
P06241 |
FYN |
Tyrosine-protein kinase Fyn |
chr6 |
PF00018 |
88 |
135 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| FYN-213 |
P06241 |
FYN |
Tyrosine-protein kinase Fyn |
chr6 |
PF00018 |
88 |
135 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| GABARAP-205 |
O95166 |
GABARAP |
Gamma-aminobutyric acid receptor-associated protein |
chr17 |
PF02991 |
13 |
116 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| GABARAP-201 |
O95166 |
GABARAP |
Gamma-aminobutyric acid receptor-associated protein |
chr17 |
PF02991 |
13 |
116 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| GALNT2-201 |
Q10471 |
GALNT2 |
Polypeptide N-acetylgalactosaminyltransferase 2 |
chr1 |
PF00652 |
446 |
563 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| GALNT2-201 |
Q10471 |
GALNT2 |
Polypeptide N-acetylgalactosaminyltransferase 2 |
chr1 |
PF00535 |
139 |
322 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| GEMIN2-202 |
O14893 |
GEMIN2 |
Gem-associated protein 2 |
chr14 |
PF04938 |
37 |
273 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| GEMIN2-213 |
O14893 |
GEMIN2 |
Gem-associated protein 2 |
chr14 |
PF04938 |
37 |
273 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| GGA1-204 |
Q9UJY5 |
GGA1 |
ADP-ribosylation factor-binding protein GGA1 |
chr22 |
PF00790 |
5 |
143 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| GGA1-204 |
Q9UJY5 |
GGA1 |
ADP-ribosylation factor-binding protein GGA1 |
chr22 |
PF02883 |
513 |
631 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| GGA1-203 |
Q9UJY5 |
GGA1 |
ADP-ribosylation factor-binding protein GGA1 |
chr22 |
PF00790 |
5 |
143 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| GGA1-203 |
Q9UJY5 |
GGA1 |
ADP-ribosylation factor-binding protein GGA1 |
chr22 |
PF02883 |
513 |
631 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| GGA1-205 |
Q9UJY5 |
GGA1 |
ADP-ribosylation factor-binding protein GGA1 |
chr22 |
PF00790 |
5 |
143 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| GGA1-205 |
Q9UJY5 |
GGA1 |
ADP-ribosylation factor-binding protein GGA1 |
chr22 |
PF02883 |
513 |
631 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| GGA3-201 |
Q9NZ52 |
GGA3 |
ADP-ribosylation factor-binding protein GGA3 |
chr17 |
PF00790 |
3 |
142 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| GGA3-214 |
Q9NZ52 |
GGA3 |
ADP-ribosylation factor-binding protein GGA3 |
chr17 |
PF00790 |
3 |
142 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| GGA3-224 |
Q9NZ52 |
GGA3 |
ADP-ribosylation factor-binding protein GGA3 |
chr17 |
PF00790 |
3 |
142 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| GGA3-212 |
Q9NZ52 |
GGA3 |
ADP-ribosylation factor-binding protein GGA3 |
chr17 |
PF00790 |
3 |
142 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| GOPC-201 |
Q9HD26 |
GOPC |
Golgi-associated PDZ and coiled-coil motif-containing protein |
chr6 |
PF00595 |
288 |
368 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| GOPC-202 |
Q9HD26 |
GOPC |
Golgi-associated PDZ and coiled-coil motif-containing protein |
chr6 |
PF00595 |
288 |
368 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| GORASP1-235 |
Q9BQQ3 |
GORASP1 |
Golgi reassembly-stacking protein 1 |
chr3 |
PF04495 |
69 |
205 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| GORASP1-203 |
Q9BQQ3 |
GORASP1 |
Golgi reassembly-stacking protein 1 |
chr3 |
PF04495 |
69 |
205 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| GORASP1-237 |
Q9BQQ3 |
GORASP1 |
Golgi reassembly-stacking protein 1 |
chr3 |
PF04495 |
69 |
205 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| GORASP1-210 |
Q9BQQ3 |
GORASP1 |
Golgi reassembly-stacking protein 1 |
chr3 |
PF04495 |
69 |
205 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| GORASP1-212 |
Q9BQQ3 |
GORASP1 |
Golgi reassembly-stacking protein 1 |
chr3 |
PF04495 |
69 |
205 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| GORASP1-201 |
Q9BQQ3 |
GORASP1 |
Golgi reassembly-stacking protein 1 |
chr3 |
PF04495 |
69 |
205 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| GORASP1-251 |
Q9BQQ3 |
GORASP1 |
Golgi reassembly-stacking protein 1 |
chr3 |
PF04495 |
69 |
205 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| GORASP1-202 |
Q9BQQ3 |
GORASP1 |
Golgi reassembly-stacking protein 1 |
chr3 |
PF04495 |
69 |
205 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| GP1BA-201 |
P07359 |
GP1BA |
Platelet glycoprotein Ib alpha chain |
chr17 |
PF13855 |
116 |
174 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| GPSM2-203 |
P81274 |
GPSM2 |
G-protein-signaling modulator 2 |
chr1 |
PF13176 |
204 |
239 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| GPSM2-218 |
P81274 |
GPSM2 |
G-protein-signaling modulator 2 |
chr1 |
PF13176 |
204 |
239 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| GPSM2-223 |
P81274 |
GPSM2 |
G-protein-signaling modulator 2 |
chr1 |
PF13176 |
204 |
239 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| GPSM2-208 |
P81274 |
GPSM2 |
G-protein-signaling modulator 2 |
chr1 |
PF13176 |
204 |
239 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| GPSM2-216 |
P81274 |
GPSM2 |
G-protein-signaling modulator 2 |
chr1 |
PF13176 |
204 |
239 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| GPSM2-201 |
P81274 |
GPSM2 |
G-protein-signaling modulator 2 |
chr1 |
PF13176 |
204 |
239 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| GPSM2-211 |
P81274 |
GPSM2 |
G-protein-signaling modulator 2 |
chr1 |
PF13176 |
204 |
239 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| GPSM2-207 |
P81274 |
GPSM2 |
G-protein-signaling modulator 2 |
chr1 |
PF13176 |
204 |
239 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| GPSM2-204 |
P81274 |
GPSM2 |
G-protein-signaling modulator 2 |
chr1 |
PF13176 |
204 |
239 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| GPSM2-205 |
P81274 |
GPSM2 |
G-protein-signaling modulator 2 |
chr1 |
PF13176 |
204 |
239 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| GPSM2-202 |
P81274 |
GPSM2 |
G-protein-signaling modulator 2 |
chr1 |
PF13176 |
204 |
239 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| GPSM2-206 |
P81274 |
GPSM2 |
G-protein-signaling modulator 2 |
chr1 |
PF13176 |
204 |
239 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| GRB7-205 |
Q14451 |
GRB7 |
Growth factor receptor-bound protein 7 |
chr17 |
PF00017 |
431 |
512 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| GRB7-204 |
Q14451 |
GRB7 |
Growth factor receptor-bound protein 7 |
chr17 |
PF00017 |
431 |
512 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| GRB7-201 |
Q14451 |
GRB7 |
Growth factor receptor-bound protein 7 |
chr17 |
PF00017 |
431 |
512 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| GRB7-203 |
Q14451 |
GRB7 |
Growth factor receptor-bound protein 7 |
chr17 |
PF00017 |
431 |
512 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| GSK3B-202 |
P49841 |
GSK3B |
Glycogen synthase kinase-3 beta |
chr3 |
PF00069 |
56 |
340 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| GSK3B-201 |
P49841 |
GSK3B |
Glycogen synthase kinase-3 beta |
chr3 |
PF00069 |
56 |
340 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| GSK3B-224 |
P49841 |
GSK3B |
Glycogen synthase kinase-3 beta |
chr3 |
PF00069 |
56 |
340 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| GSK3B-239 |
P49841 |
GSK3B |
Glycogen synthase kinase-3 beta |
chr3 |
PF00069 |
56 |
340 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| GSK3B-227 |
P49841 |
GSK3B |
Glycogen synthase kinase-3 beta |
chr3 |
PF00069 |
56 |
340 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| GZMH-202 |
P20718 |
GZMH |
Granzyme H |
chr14 |
PF00089 |
21 |
239 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| GZMH-201 |
P20718 |
GZMH |
Granzyme H |
chr14 |
PF00089 |
21 |
239 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| GZMH-203 |
P20718 |
GZMH |
Granzyme H |
chr14 |
PF00089 |
21 |
239 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| GZMM-201 |
P51124 |
GZMM |
Granzyme M |
chr19 |
PF00089 |
26 |
249 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| HAT1-201 |
O14929 |
HAT1 |
Histone acetyltransferase type B catalytic subunit |
chr2 |
PF10394 |
25 |
187 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| HGFAC-201 |
Q04756 |
HGFAC |
Hepatocyte growth factor activator |
chr4 |
PF00089 |
408 |
641 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| HGFAC-204 |
Q04756 |
HGFAC |
Hepatocyte growth factor activator |
chr4 |
PF00089 |
408 |
641 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| HIF1AN-201 |
Q9NWT6 |
HIF1AN |
Hypoxia-inducible factor 1-alpha inhibitor |
chr10 |
PF13621 |
48 |
302 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| HLA-B-261 |
P01889 |
HLA-B |
HLA class I histocompatibility antigen, B alpha chain |
chr6 |
PF07654 |
211 |
290 |
Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| HLA-B-261 |
P01889 |
HLA-B |
HLA class I histocompatibility antigen, B alpha chain |
chr6 |
PF00129 |
25 |
203 |
Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| HLA-B-249 |
P01889 |
HLA-B |
HLA class I histocompatibility antigen, B alpha chain |
chr6 |
PF07654 |
211 |
290 |
Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| HLA-B-249 |
P01889 |
HLA-B |
HLA class I histocompatibility antigen, B alpha chain |
chr6 |
PF00129 |
25 |
203 |
Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| HLA-B-257 |
P01889 |
HLA-B |
HLA class I histocompatibility antigen, B alpha chain |
chr6 |
PF07654 |
211 |
290 |
Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| HLA-B-257 |
P01889 |
HLA-B |
HLA class I histocompatibility antigen, B alpha chain |
chr6 |
PF00129 |
25 |
203 |
Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| HLA-B-259 |
P01889 |
HLA-B |
HLA class I histocompatibility antigen, B alpha chain |
chr6 |
PF07654 |
211 |
290 |
Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| HLA-B-259 |
P01889 |
HLA-B |
HLA class I histocompatibility antigen, B alpha chain |
chr6 |
PF00129 |
25 |
203 |
Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| HLA-B-260 |
P01889 |
HLA-B |
HLA class I histocompatibility antigen, B alpha chain |
chr6 |
PF07654 |
211 |
290 |
Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| HLA-B-260 |
P01889 |
HLA-B |
HLA class I histocompatibility antigen, B alpha chain |
chr6 |
PF00129 |
25 |
203 |
Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| HLA-B-258 |
P01889 |
HLA-B |
HLA class I histocompatibility antigen, B alpha chain |
chr6 |
PF07654 |
211 |
290 |
Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| HLA-B-258 |
P01889 |
HLA-B |
HLA class I histocompatibility antigen, B alpha chain |
chr6 |
PF00129 |
25 |
203 |
Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| HLA-E-201 |
P13747 |
HLA-E |
HLA class I histocompatibility antigen, alpha chain E |
chr6 |
PF07654 |
207 |
287 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| HLA-E-201 |
P13747 |
HLA-E |
HLA class I histocompatibility antigen, alpha chain E |
chr6 |
PF00129 |
22 |
200 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| HLA-G-201 |
P17693 |
HLA-G |
HLA class I histocompatibility antigen, alpha chain G |
chr6 |
PF00129 |
25 |
203 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| HLA-G-201 |
P17693 |
HLA-G |
HLA class I histocompatibility antigen, alpha chain G |
chr6 |
PF07654 |
211 |
290 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| HLA-G-204 |
P17693 |
HLA-G |
HLA class I histocompatibility antigen, alpha chain G |
chr6 |
PF00129 |
25 |
203 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| HLA-G-204 |
P17693 |
HLA-G |
HLA class I histocompatibility antigen, alpha chain G |
chr6 |
PF07654 |
211 |
290 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| HNF4A-202 |
P41235 |
HNF4A |
Hepatocyte nuclear factor 4-alpha |
chr20 |
PF00104 |
172 |
361 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| HNF4A-204 |
P41235 |
HNF4A |
Hepatocyte nuclear factor 4-alpha |
chr20 |
PF00104 |
172 |
361 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| HNF4A-201 |
P41235 |
HNF4A |
Hepatocyte nuclear factor 4-alpha |
chr20 |
PF00104 |
172 |
361 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| IGF1R-216 |
P08069 |
IGF1R |
Insulin-like growth factor 1 receptor |
chr15 |
PF07714 |
999 |
1266 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| IGF1R-217 |
P08069 |
IGF1R |
Insulin-like growth factor 1 receptor |
chr15 |
PF07714 |
999 |
1266 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| INSR-201 |
P06213 |
INSR |
Insulin receptor |
chr19 |
PF07714 |
1023 |
1290 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| INSR-202 |
P06213 |
INSR |
Insulin receptor |
chr19 |
PF07714 |
1023 |
1290 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| INTS3-204 |
Q68E01 |
INTS3 |
Integrator complex subunit 3 |
chr1 |
PF10189 |
271 |
495 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| INTS3-201 |
Q68E01 |
INTS3 |
Integrator complex subunit 3 |
chr1 |
PF10189 |
271 |
495 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| ITCH-201 |
Q96J02 |
ITCH |
E3 ubiquitin-protein ligase Itchy homolog |
chr20 |
PF00397 |
480 |
509 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| ITCH-206 |
Q96J02 |
ITCH |
E3 ubiquitin-protein ligase Itchy homolog |
chr20 |
PF00397 |
480 |
509 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| ITCH-210 |
Q96J02 |
ITCH |
E3 ubiquitin-protein ligase Itchy homolog |
chr20 |
PF00397 |
480 |
509 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| KAT6A-202 |
Q92794 |
KAT6A |
Histone acetyltransferase KAT6A |
chr8 |
PF00628 |
264 |
313 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| KAT6A-203 |
Q92794 |
KAT6A |
Histone acetyltransferase KAT6A |
chr8 |
PF00628 |
264 |
313 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| KAT6A-213 |
Q92794 |
KAT6A |
Histone acetyltransferase KAT6A |
chr8 |
PF00628 |
264 |
313 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| KAT6A-215 |
Q92794 |
KAT6A |
Histone acetyltransferase KAT6A |
chr8 |
PF00628 |
264 |
313 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| KAT6A-205 |
Q92794 |
KAT6A |
Histone acetyltransferase KAT6A |
chr8 |
PF00628 |
264 |
313 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| KAT6A-201 |
Q92794 |
KAT6A |
Histone acetyltransferase KAT6A |
chr8 |
PF00628 |
264 |
313 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| KAT6A-208 |
Q92794 |
KAT6A |
Histone acetyltransferase KAT6A |
chr8 |
PF00628 |
264 |
313 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| KDM1B-205 |
Q8NB78 |
KDM1B |
Lysine-specific histone demethylase 2 |
chr6 |
PF03486 |
355 |
635 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| KDM1B-205 |
Q8NB78 |
KDM1B |
Lysine-specific histone demethylase 2 |
chr6 |
PF07992 |
355 |
635 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| KDM1B-202 |
Q8NB78 |
KDM1B |
Lysine-specific histone demethylase 2 |
chr6 |
PF03486 |
355 |
635 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| KDM1B-202 |
Q8NB78 |
KDM1B |
Lysine-specific histone demethylase 2 |
chr6 |
PF07992 |
355 |
635 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| KLHL2-201 |
O95198 |
KLHL2 |
Kelch-like protein 2 |
chr4 |
PF01344 |
532 |
577 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| KLHL2-209 |
O95198 |
KLHL2 |
Kelch-like protein 2 |
chr4 |
PF01344 |
532 |
577 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| KLHL3-209 |
Q9UH77 |
KLHL3 |
Kelch-like protein 3 |
chr5 |
PF01344 |
526 |
571 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| KLHL3-201 |
Q9UH77 |
KLHL3 |
Kelch-like protein 3 |
chr5 |
PF01344 |
526 |
571 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| KLK4-201 |
Q9Y5K2 |
KLK4 |
Kallikrein-4 |
chr19 |
PF00089 |
31 |
247 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| KPNA2-212 |
P52292 |
KPNA2 |
Importin subunit alpha-1 |
chr17 |
PF00514 |
409 |
448 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| KPNA2-203 |
P52292 |
KPNA2 |
Importin subunit alpha-1 |
chr17 |
PF00514 |
409 |
448 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| KPNA2-202 |
P52292 |
KPNA2 |
Importin subunit alpha-1 |
chr17 |
PF00514 |
409 |
448 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| KPNA2-207 |
P52292 |
KPNA2 |
Importin subunit alpha-1 |
chr17 |
PF00514 |
409 |
448 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| KPNA2-208 |
P52292 |
KPNA2 |
Importin subunit alpha-1 |
chr17 |
PF00514 |
409 |
448 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| KPNA2-201 |
P52292 |
KPNA2 |
Importin subunit alpha-1 |
chr17 |
PF00514 |
409 |
448 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| KPNA2-220 |
P52292 |
KPNA2 |
Importin subunit alpha-1 |
chr17 |
PF00514 |
409 |
448 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| KPNA2-216 |
P52292 |
KPNA2 |
Importin subunit alpha-1 |
chr17 |
PF00514 |
409 |
448 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| KPNA2-210 |
P52292 |
KPNA2 |
Importin subunit alpha-1 |
chr17 |
PF00514 |
409 |
448 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| KPNA2-219 |
P52292 |
KPNA2 |
Importin subunit alpha-1 |
chr17 |
PF00514 |
409 |
448 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| KPNB1-214 |
Q14974 |
KPNB1 |
Importin subunit beta-1 |
chr17 |
PF03810 |
21 |
101 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| KPNB1-201 |
Q14974 |
KPNB1 |
Importin subunit beta-1 |
chr17 |
PF03810 |
21 |
101 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| KRIT1-237 |
O00522 |
KRIT1 |
Krev interaction trapped protein 1 |
chr7 |
PF00373 |
517 |
640 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| KRIT1-215 |
O00522 |
KRIT1 |
Krev interaction trapped protein 1 |
chr7 |
PF00373 |
517 |
640 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| KRIT1-252 |
O00522 |
KRIT1 |
Krev interaction trapped protein 1 |
chr7 |
PF00373 |
517 |
640 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| KRIT1-201 |
O00522 |
KRIT1 |
Krev interaction trapped protein 1 |
chr7 |
PF00373 |
517 |
640 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| KRIT1-245 |
O00522 |
KRIT1 |
Krev interaction trapped protein 1 |
chr7 |
PF00373 |
517 |
640 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| KRIT1-241 |
O00522 |
KRIT1 |
Krev interaction trapped protein 1 |
chr7 |
PF00373 |
517 |
640 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| KRIT1-203 |
O00522 |
KRIT1 |
Krev interaction trapped protein 1 |
chr7 |
PF00373 |
517 |
640 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| KRIT1-269 |
O00522 |
KRIT1 |
Krev interaction trapped protein 1 |
chr7 |
PF00373 |
517 |
640 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| KRIT1-261 |
O00522 |
KRIT1 |
Krev interaction trapped protein 1 |
chr7 |
PF00373 |
517 |
640 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| KRIT1-204 |
O00522 |
KRIT1 |
Krev interaction trapped protein 1 |
chr7 |
PF00373 |
517 |
640 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| KRIT1-234 |
O00522 |
KRIT1 |
Krev interaction trapped protein 1 |
chr7 |
PF00373 |
517 |
640 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| KRIT1-212 |
O00522 |
KRIT1 |
Krev interaction trapped protein 1 |
chr7 |
PF00373 |
517 |
640 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| KRIT1-255 |
O00522 |
KRIT1 |
Krev interaction trapped protein 1 |
chr7 |
PF00373 |
517 |
640 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| KRIT1-216 |
O00522 |
KRIT1 |
Krev interaction trapped protein 1 |
chr7 |
PF00373 |
517 |
640 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| KRIT1-268 |
O00522 |
KRIT1 |
Krev interaction trapped protein 1 |
chr7 |
PF00373 |
517 |
640 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| KRIT1-213 |
O00522 |
KRIT1 |
Krev interaction trapped protein 1 |
chr7 |
PF00373 |
517 |
640 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| KRIT1-259 |
O00522 |
KRIT1 |
Krev interaction trapped protein 1 |
chr7 |
PF00373 |
517 |
640 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| KRIT1-224 |
O00522 |
KRIT1 |
Krev interaction trapped protein 1 |
chr7 |
PF00373 |
517 |
640 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| KRIT1-243 |
O00522 |
KRIT1 |
Krev interaction trapped protein 1 |
chr7 |
PF00373 |
517 |
640 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| KRIT1-253 |
O00522 |
KRIT1 |
Krev interaction trapped protein 1 |
chr7 |
PF00373 |
517 |
640 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| KRIT1-254 |
O00522 |
KRIT1 |
Krev interaction trapped protein 1 |
chr7 |
PF00373 |
517 |
640 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| KRIT1-264 |
O00522 |
KRIT1 |
Krev interaction trapped protein 1 |
chr7 |
PF00373 |
517 |
640 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| KRIT1-231 |
O00522 |
KRIT1 |
Krev interaction trapped protein 1 |
chr7 |
PF00373 |
517 |
640 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| KRIT1-208 |
O00522 |
KRIT1 |
Krev interaction trapped protein 1 |
chr7 |
PF00373 |
517 |
640 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| KRIT1-217 |
O00522 |
KRIT1 |
Krev interaction trapped protein 1 |
chr7 |
PF00373 |
517 |
640 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| KRIT1-232 |
O00522 |
KRIT1 |
Krev interaction trapped protein 1 |
chr7 |
PF00373 |
517 |
640 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| KRIT1-248 |
O00522 |
KRIT1 |
Krev interaction trapped protein 1 |
chr7 |
PF00373 |
517 |
640 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| KRIT1-205 |
O00522 |
KRIT1 |
Krev interaction trapped protein 1 |
chr7 |
PF00373 |
517 |
640 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| KRIT1-228 |
O00522 |
KRIT1 |
Krev interaction trapped protein 1 |
chr7 |
PF00373 |
517 |
640 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| LCN2-203 |
P80188 |
LCN2 |
Neutrophil gelatinase-associated lipocalin |
chr9 |
PF00061 |
48 |
193 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| LCN2-202 |
P80188 |
LCN2 |
Neutrophil gelatinase-associated lipocalin |
chr9 |
PF00061 |
48 |
193 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| LCN2-201 |
P80188 |
LCN2 |
Neutrophil gelatinase-associated lipocalin |
chr9 |
PF00061 |
48 |
193 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| LGALS8-206 |
O00214 |
LGALS8 |
Galectin-8 |
chr1 |
PF00337 |
186 |
316 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| LGALS8-203 |
O00214 |
LGALS8 |
Galectin-8 |
chr1 |
PF00337 |
186 |
316 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| LGALS8-215 |
O00214 |
LGALS8 |
Galectin-8 |
chr1 |
PF00337 |
186 |
316 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| LGALS8-213 |
O00214 |
LGALS8 |
Galectin-8 |
chr1 |
PF00337 |
186 |
316 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| LGALS8-209 |
O00214 |
LGALS8 |
Galectin-8 |
chr1 |
PF00337 |
186 |
316 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| LGALS8-207 |
O00214 |
LGALS8 |
Galectin-8 |
chr1 |
PF00337 |
186 |
316 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| LGALS8-220 |
O00214 |
LGALS8 |
Galectin-8 |
chr1 |
PF00337 |
186 |
316 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| LGALS8-225 |
O00214 |
LGALS8 |
Galectin-8 |
chr1 |
PF00337 |
186 |
316 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| LIG4-213 |
P49917 |
LIG4 |
DNA ligase 4 |
chr13 |
PF04675 |
15 |
208 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| LIG4-216 |
P49917 |
LIG4 |
DNA ligase 4 |
chr13 |
PF04675 |
15 |
208 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| LIG4-218 |
P49917 |
LIG4 |
DNA ligase 4 |
chr13 |
PF04675 |
15 |
208 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| LIG4-210 |
P49917 |
LIG4 |
DNA ligase 4 |
chr13 |
PF04675 |
15 |
208 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| LIG4-204 |
P49917 |
LIG4 |
DNA ligase 4 |
chr13 |
PF04675 |
15 |
208 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| LIG4-203 |
P49917 |
LIG4 |
DNA ligase 4 |
chr13 |
PF04675 |
15 |
208 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| LIG4-208 |
P49917 |
LIG4 |
DNA ligase 4 |
chr13 |
PF04675 |
15 |
208 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| LIG4-209 |
P49917 |
LIG4 |
DNA ligase 4 |
chr13 |
PF04675 |
15 |
208 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| LIG4-207 |
P49917 |
LIG4 |
DNA ligase 4 |
chr13 |
PF04675 |
15 |
208 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| LIG4-217 |
P49917 |
LIG4 |
DNA ligase 4 |
chr13 |
PF04675 |
15 |
208 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| LIG4-219 |
P49917 |
LIG4 |
DNA ligase 4 |
chr13 |
PF04675 |
15 |
208 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| LIG4-214 |
P49917 |
LIG4 |
DNA ligase 4 |
chr13 |
PF04675 |
15 |
208 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| LIG4-206 |
P49917 |
LIG4 |
DNA ligase 4 |
chr13 |
PF04675 |
15 |
208 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| LIG4-211 |
P49917 |
LIG4 |
DNA ligase 4 |
chr13 |
PF04675 |
15 |
208 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| LIG4-215 |
P49917 |
LIG4 |
DNA ligase 4 |
chr13 |
PF04675 |
15 |
208 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| LIG4-205 |
P49917 |
LIG4 |
DNA ligase 4 |
chr13 |
PF04675 |
15 |
208 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| LIG4-212 |
P49917 |
LIG4 |
DNA ligase 4 |
chr13 |
PF04675 |
15 |
208 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| LIG4-201 |
P49917 |
LIG4 |
DNA ligase 4 |
chr13 |
PF04675 |
15 |
208 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| LIG4-202 |
P49917 |
LIG4 |
DNA ligase 4 |
chr13 |
PF04675 |
15 |
208 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| LRP6-203 |
O75581 |
LRP6 |
Low-density lipoprotein receptor-related protein 6 |
chr12 |
PF14670 |
893 |
929 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| LRP6-201 |
O75581 |
LRP6 |
Low-density lipoprotein receptor-related protein 6 |
chr12 |
PF14670 |
893 |
929 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAD2L1-201 |
Q13257 |
MAD2L1 |
Mitotic spindle assembly checkpoint protein MAD2A |
chr4 |
PF02301 |
16 |
196 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAD2L1-202 |
Q13257 |
MAD2L1 |
Mitotic spindle assembly checkpoint protein MAD2A |
chr4 |
PF02301 |
16 |
196 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAD2L2-211 |
Q9UI95 |
MAD2L2 |
Mitotic spindle assembly checkpoint protein MAD2B |
chr1 |
PF02301 |
16 |
135 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAD2L2-201 |
Q9UI95 |
MAD2L2 |
Mitotic spindle assembly checkpoint protein MAD2B |
chr1 |
PF02301 |
16 |
135 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAD2L2-206 |
Q9UI95 |
MAD2L2 |
Mitotic spindle assembly checkpoint protein MAD2B |
chr1 |
PF02301 |
16 |
135 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAD2L2-209 |
Q9UI95 |
MAD2L2 |
Mitotic spindle assembly checkpoint protein MAD2B |
chr1 |
PF02301 |
16 |
135 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAD2L2-207 |
Q9UI95 |
MAD2L2 |
Mitotic spindle assembly checkpoint protein MAD2B |
chr1 |
PF02301 |
16 |
135 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAD2L2-212 |
Q9UI95 |
MAD2L2 |
Mitotic spindle assembly checkpoint protein MAD2B |
chr1 |
PF02301 |
16 |
135 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAD2L2-204 |
Q9UI95 |
MAD2L2 |
Mitotic spindle assembly checkpoint protein MAD2B |
chr1 |
PF02301 |
16 |
135 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAD2L2-205 |
Q9UI95 |
MAD2L2 |
Mitotic spindle assembly checkpoint protein MAD2B |
chr1 |
PF02301 |
16 |
135 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK1-202 |
P28482 |
MAPK1 |
Mitogen-activated protein kinase 1 |
chr22 |
PF00069 |
25 |
313 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK1-201 |
P28482 |
MAPK1 |
Mitogen-activated protein kinase 1 |
chr22 |
PF00069 |
25 |
313 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-369 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-313 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-241 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-239 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-356 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-338 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-271 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-228 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-333 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-278 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-264 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-349 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-336 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-233 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-340 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-375 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-377 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-221 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-352 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-319 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-252 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-269 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-284 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-391 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-388 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-302 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-320 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-379 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-283 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-367 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-341 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-311 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-229 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-296 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-337 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-365 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-234 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-272 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-225 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-209 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-321 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-306 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-206 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-279 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-265 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-364 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-316 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-344 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-297 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-318 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-371 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-295 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-343 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-317 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-345 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-216 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-223 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-232 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-244 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-248 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-261 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-370 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-303 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-351 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-235 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-222 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-362 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-231 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-372 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-258 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-327 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-368 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-353 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-378 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-323 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK10-266 |
P53779 |
MAPK10 |
Mitogen-activated protein kinase 10 |
chr4 |
PF00069 |
64 |
359 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK14-203 |
Q16539 |
MAPK14 |
Mitogen-activated protein kinase 14 |
chr6 |
PF00069 |
24 |
308 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK14-202 |
Q16539 |
MAPK14 |
Mitogen-activated protein kinase 14 |
chr6 |
PF00069 |
24 |
308 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK14-201 |
Q16539 |
MAPK14 |
Mitogen-activated protein kinase 14 |
chr6 |
PF00069 |
24 |
308 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK8-206 |
P45983 |
MAPK8 |
Mitogen-activated protein kinase 8 |
chr10 |
PF00069 |
26 |
321 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK8-208 |
P45983 |
MAPK8 |
Mitogen-activated protein kinase 8 |
chr10 |
PF00069 |
26 |
321 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK8-215 |
P45983 |
MAPK8 |
Mitogen-activated protein kinase 8 |
chr10 |
PF00069 |
26 |
321 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK8-203 |
P45983 |
MAPK8 |
Mitogen-activated protein kinase 8 |
chr10 |
PF00069 |
26 |
321 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK8-209 |
P45983 |
MAPK8 |
Mitogen-activated protein kinase 8 |
chr10 |
PF00069 |
26 |
321 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK8-207 |
P45983 |
MAPK8 |
Mitogen-activated protein kinase 8 |
chr10 |
PF00069 |
26 |
321 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPK8-210 |
P45983 |
MAPK8 |
Mitogen-activated protein kinase 8 |
chr10 |
PF00069 |
26 |
321 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MAPRE1-201 |
Q15691 |
MAPRE1 |
Microtubule-associated protein RP/EB family member 1 |
chr20 |
PF03271 |
210 |
248 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MARK2-204 |
Q7KZI7 |
MARK2 |
Serine/threonine-protein kinase MARK2 |
chr11 |
PF00627 |
324 |
360 |
Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MARK2-209 |
Q7KZI7 |
MARK2 |
Serine/threonine-protein kinase MARK2 |
chr11 |
PF00627 |
324 |
360 |
Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MARK2-211 |
Q7KZI7 |
MARK2 |
Serine/threonine-protein kinase MARK2 |
chr11 |
PF00627 |
324 |
360 |
Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MARK2-206 |
Q7KZI7 |
MARK2 |
Serine/threonine-protein kinase MARK2 |
chr11 |
PF00627 |
324 |
360 |
Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MARK2-207 |
Q7KZI7 |
MARK2 |
Serine/threonine-protein kinase MARK2 |
chr11 |
PF00627 |
324 |
360 |
Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MASP2-208 |
O00187 |
MASP2 |
Mannan-binding lectin serine protease 2 |
chr1 |
PF00089 |
445 |
679 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MASP2-202 |
O00187 |
MASP2 |
Mannan-binding lectin serine protease 2 |
chr1 |
PF00089 |
445 |
679 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MASP2-214 |
O00187 |
MASP2 |
Mannan-binding lectin serine protease 2 |
chr1 |
PF00089 |
445 |
679 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MASP2-216 |
O00187 |
MASP2 |
Mannan-binding lectin serine protease 2 |
chr1 |
PF00089 |
445 |
679 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MASP2-207 |
O00187 |
MASP2 |
Mannan-binding lectin serine protease 2 |
chr1 |
PF00089 |
445 |
679 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MASP2-201 |
O00187 |
MASP2 |
Mannan-binding lectin serine protease 2 |
chr1 |
PF00089 |
445 |
679 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MASP2-209 |
O00187 |
MASP2 |
Mannan-binding lectin serine protease 2 |
chr1 |
PF00089 |
445 |
679 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MASP2-211 |
O00187 |
MASP2 |
Mannan-binding lectin serine protease 2 |
chr1 |
PF00089 |
445 |
679 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MASP2-215 |
O00187 |
MASP2 |
Mannan-binding lectin serine protease 2 |
chr1 |
PF00089 |
445 |
679 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MCL1-208 |
Q07820 |
MCL1 |
Induced myeloid leukemia cell differentiation protein Mcl-1 |
chr1 |
PF00452 |
213 |
312 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MCL1-202 |
Q07820 |
MCL1 |
Induced myeloid leukemia cell differentiation protein Mcl-1 |
chr1 |
PF00452 |
213 |
312 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MDM2-224 |
Q00987 |
MDM2 |
E3 ubiquitin-protein ligase Mdm2 |
chr12 |
PF02201 |
26 |
101 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MDM2-220 |
Q00987 |
MDM2 |
E3 ubiquitin-protein ligase Mdm2 |
chr12 |
PF02201 |
26 |
101 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MDM2-202 |
Q00987 |
MDM2 |
E3 ubiquitin-protein ligase Mdm2 |
chr12 |
PF02201 |
26 |
101 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MDM2-207 |
Q00987 |
MDM2 |
E3 ubiquitin-protein ligase Mdm2 |
chr12 |
PF02201 |
26 |
101 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MDM2-232 |
Q00987 |
MDM2 |
E3 ubiquitin-protein ligase Mdm2 |
chr12 |
PF02201 |
26 |
101 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MDM2-227 |
Q00987 |
MDM2 |
E3 ubiquitin-protein ligase Mdm2 |
chr12 |
PF02201 |
26 |
101 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MDM2-210 |
Q00987 |
MDM2 |
E3 ubiquitin-protein ligase Mdm2 |
chr12 |
PF02201 |
26 |
101 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MDM2-212 |
Q00987 |
MDM2 |
E3 ubiquitin-protein ligase Mdm2 |
chr12 |
PF02201 |
26 |
101 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MDM2-225 |
Q00987 |
MDM2 |
E3 ubiquitin-protein ligase Mdm2 |
chr12 |
PF02201 |
26 |
101 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MDM2-219 |
Q00987 |
MDM2 |
E3 ubiquitin-protein ligase Mdm2 |
chr12 |
PF02201 |
26 |
101 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MDM4-213 |
O15151 |
MDM4 |
Protein Mdm4 |
chr1 |
PF02201 |
25 |
95 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MDM4-203 |
O15151 |
MDM4 |
Protein Mdm4 |
chr1 |
PF02201 |
25 |
95 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MDM4-216 |
O15151 |
MDM4 |
Protein Mdm4 |
chr1 |
PF02201 |
25 |
95 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MDM4-205 |
O15151 |
MDM4 |
Protein Mdm4 |
chr1 |
PF02201 |
25 |
95 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| MOB1A-201 |
Q9H8S9 |
MOB1A |
MOB kinase activator 1A |
chr2 |
PF03637 |
33 |
204 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| NAA40-206 |
Q86UY6 |
NAA40 |
N-alpha-acetyltransferase 40 |
chr11 |
PF00583 |
71 |
192 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| NAA40-202 |
Q86UY6 |
NAA40 |
N-alpha-acetyltransferase 40 |
chr11 |
PF00583 |
71 |
192 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| NCF1-201 |
P14598 |
NCF1 |
Neutrophil cytosol factor 1 |
chr7 |
PF00018 |
232 |
277 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| NPR3-203 |
P17342 |
NPR3 |
Atrial natriuretic peptide receptor 3 |
chr5 |
PF01094 |
71 |
425 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| NPR3-201 |
P17342 |
NPR3 |
Atrial natriuretic peptide receptor 3 |
chr5 |
PF01094 |
71 |
425 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| NR1H2-204 |
P55055 |
NR1H2 |
Oxysterols receptor LXR-beta |
chr19 |
PF00104 |
256 |
444 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| NR1H2-208 |
P55055 |
NR1H2 |
Oxysterols receptor LXR-beta |
chr19 |
PF00104 |
256 |
444 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| NR1H2-209 |
P55055 |
NR1H2 |
Oxysterols receptor LXR-beta |
chr19 |
PF00104 |
256 |
444 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| NR1H2-207 |
P55055 |
NR1H2 |
Oxysterols receptor LXR-beta |
chr19 |
PF00104 |
256 |
444 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| NR1H2-201 |
P55055 |
NR1H2 |
Oxysterols receptor LXR-beta |
chr19 |
PF00104 |
256 |
444 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| NR1H2-214 |
P55055 |
NR1H2 |
Oxysterols receptor LXR-beta |
chr19 |
PF00104 |
256 |
444 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| NR1H3-214 |
Q13133 |
NR1H3 |
Oxysterols receptor LXR-alpha |
chr11 |
PF00104 |
243 |
431 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| NR1H3-213 |
Q13133 |
NR1H3 |
Oxysterols receptor LXR-alpha |
chr11 |
PF00104 |
243 |
431 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| NR1H3-235 |
Q13133 |
NR1H3 |
Oxysterols receptor LXR-alpha |
chr11 |
PF00104 |
243 |
431 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| NR1H3-209 |
Q13133 |
NR1H3 |
Oxysterols receptor LXR-alpha |
chr11 |
PF00104 |
243 |
431 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| NR1H3-212 |
Q13133 |
NR1H3 |
Oxysterols receptor LXR-alpha |
chr11 |
PF00104 |
243 |
431 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| NR1H3-210 |
Q13133 |
NR1H3 |
Oxysterols receptor LXR-alpha |
chr11 |
PF00104 |
243 |
431 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| NR1H3-211 |
Q13133 |
NR1H3 |
Oxysterols receptor LXR-alpha |
chr11 |
PF00104 |
243 |
431 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| NR1H3-217 |
Q13133 |
NR1H3 |
Oxysterols receptor LXR-alpha |
chr11 |
PF00104 |
243 |
431 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| NR1H3-208 |
Q13133 |
NR1H3 |
Oxysterols receptor LXR-alpha |
chr11 |
PF00104 |
243 |
431 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| NR1H4-201 |
Q96RI1 |
NR1H4 |
Bile acid receptor |
chr12 |
PF00104 |
289 |
471 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| NR1H4-209 |
Q96RI1 |
NR1H4 |
Bile acid receptor |
chr12 |
PF00104 |
289 |
471 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| NR1H4-203 |
Q96RI1 |
NR1H4 |
Bile acid receptor |
chr12 |
PF00104 |
289 |
471 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| NR1H4-210 |
Q96RI1 |
NR1H4 |
Bile acid receptor |
chr12 |
PF00104 |
289 |
471 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| NR1H4-206 |
Q96RI1 |
NR1H4 |
Bile acid receptor |
chr12 |
PF00104 |
289 |
471 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| NR1I2-202 |
O75469 |
NR1I2 |
Nuclear receptor subfamily 1 group I member 2 |
chr3 |
PF00104 |
238 |
415 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| NR1I2-201 |
O75469 |
NR1I2 |
Nuclear receptor subfamily 1 group I member 2 |
chr3 |
PF00104 |
238 |
415 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| NR3C1-212 |
P04150 |
NR3C1 |
Glucocorticoid receptor |
chr5 |
PF00104 |
549 |
741 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| NR3C1-205 |
P04150 |
NR3C1 |
Glucocorticoid receptor |
chr5 |
PF00104 |
549 |
741 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| NR3C1-204 |
P04150 |
NR3C1 |
Glucocorticoid receptor |
chr5 |
PF00104 |
549 |
741 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| NR3C1-206 |
P04150 |
NR3C1 |
Glucocorticoid receptor |
chr5 |
PF00104 |
549 |
741 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| NR3C1-201 |
P04150 |
NR3C1 |
Glucocorticoid receptor |
chr5 |
PF00104 |
549 |
741 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| NR3C1-217 |
P04150 |
NR3C1 |
Glucocorticoid receptor |
chr5 |
PF00104 |
549 |
741 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| NR3C1-209 |
P04150 |
NR3C1 |
Glucocorticoid receptor |
chr5 |
PF00104 |
549 |
741 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| NR3C1-203 |
P04150 |
NR3C1 |
Glucocorticoid receptor |
chr5 |
PF00104 |
549 |
741 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| NR3C1-202 |
P04150 |
NR3C1 |
Glucocorticoid receptor |
chr5 |
PF00104 |
549 |
741 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| NR3C2-209 |
P08235 |
NR3C2 |
Mineralocorticoid receptor |
chr4 |
PF00104 |
757 |
946 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| NR3C2-203 |
P08235 |
NR3C2 |
Mineralocorticoid receptor |
chr4 |
PF00104 |
757 |
946 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| NR3C2-207 |
P08235 |
NR3C2 |
Mineralocorticoid receptor |
chr4 |
PF00104 |
757 |
946 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| NR3C2-202 |
P08235 |
NR3C2 |
Mineralocorticoid receptor |
chr4 |
PF00104 |
757 |
946 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| NR5A1-203 |
Q13285 |
NR5A1 |
Steroidogenic factor 1 |
chr9 |
PF00104 |
250 |
442 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| NR5A1-202 |
Q13285 |
NR5A1 |
Steroidogenic factor 1 |
chr9 |
PF00104 |
250 |
442 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| NR5A2-205 |
O00482 |
NR5A2 |
Nuclear receptor subfamily 5 group A member 2 |
chr1 |
PF00104 |
330 |
523 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| NR5A2-203 |
O00482 |
NR5A2 |
Nuclear receptor subfamily 5 group A member 2 |
chr1 |
PF00104 |
330 |
523 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| OGT-202 |
O15294 |
OGT |
UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit |
chrX |
PF13844 |
476 |
1016 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| OGT-202 |
O15294 |
OGT |
UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit |
chrX |
PF13414 |
436 |
474 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| OGT-212 |
O15294 |
OGT |
UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit |
chrX |
PF13844 |
476 |
1016 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| OGT-212 |
O15294 |
OGT |
UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit |
chrX |
PF13414 |
436 |
474 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| OGT-217 |
O15294 |
OGT |
UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit |
chrX |
PF13844 |
476 |
1016 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| OGT-217 |
O15294 |
OGT |
UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit |
chrX |
PF13414 |
436 |
474 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| OGT-221 |
O15294 |
OGT |
UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit |
chrX |
PF13844 |
476 |
1016 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| OGT-221 |
O15294 |
OGT |
UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit |
chrX |
PF13414 |
436 |
474 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| OGT-201 |
O15294 |
OGT |
UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit |
chrX |
PF13844 |
476 |
1016 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| OGT-201 |
O15294 |
OGT |
UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit |
chrX |
PF13414 |
436 |
474 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| OGT-218 |
O15294 |
OGT |
UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit |
chrX |
PF13844 |
476 |
1016 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| OGT-218 |
O15294 |
OGT |
UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit |
chrX |
PF13414 |
436 |
474 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| OXSR1-201 |
O95747 |
OXSR1 |
Serine/threonine-protein kinase OSR1 |
chr3 |
PF12202 |
434 |
491 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| OXSR1-202 |
O95747 |
OXSR1 |
Serine/threonine-protein kinase OSR1 |
chr3 |
PF12202 |
434 |
491 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PABPC1-228 |
P11940 |
PABPC1 |
Polyadenylate-binding protein 1 |
chr8 |
PF00658 |
547 |
614 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PABPC1-217 |
P11940 |
PABPC1 |
Polyadenylate-binding protein 1 |
chr8 |
PF00658 |
547 |
614 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PABPC1-214 |
P11940 |
PABPC1 |
Polyadenylate-binding protein 1 |
chr8 |
PF00658 |
547 |
614 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PABPC1-231 |
P11940 |
PABPC1 |
Polyadenylate-binding protein 1 |
chr8 |
PF00658 |
547 |
614 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PABPC1-218 |
P11940 |
PABPC1 |
Polyadenylate-binding protein 1 |
chr8 |
PF00658 |
547 |
614 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PABPC1-210 |
P11940 |
PABPC1 |
Polyadenylate-binding protein 1 |
chr8 |
PF00658 |
547 |
614 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PABPC1-221 |
P11940 |
PABPC1 |
Polyadenylate-binding protein 1 |
chr8 |
PF00658 |
547 |
614 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PABPC1-220 |
P11940 |
PABPC1 |
Polyadenylate-binding protein 1 |
chr8 |
PF00658 |
547 |
614 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PABPC1-222 |
P11940 |
PABPC1 |
Polyadenylate-binding protein 1 |
chr8 |
PF00658 |
547 |
614 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PABPC1-208 |
P11940 |
PABPC1 |
Polyadenylate-binding protein 1 |
chr8 |
PF00658 |
547 |
614 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PABPC1-201 |
P11940 |
PABPC1 |
Polyadenylate-binding protein 1 |
chr8 |
PF00658 |
547 |
614 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PABPC1-215 |
P11940 |
PABPC1 |
Polyadenylate-binding protein 1 |
chr8 |
PF00658 |
547 |
614 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PADI4-201 |
Q9UM07 |
PADI4 |
Protein-arginine deiminase type-4 |
chr1 |
PF03068 |
283 |
660 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PADI4-201 |
Q9UM07 |
PADI4 |
Protein-arginine deiminase type-4 |
chr1 |
PF08526 |
1 |
111 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PADI4-201 |
Q9UM07 |
PADI4 |
Protein-arginine deiminase type-4 |
chr1 |
PF08527 |
113 |
273 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PAK4-210 |
O96013 |
PAK4 |
Serine/threonine-protein kinase PAK 4 |
chr19 |
PF00069 |
321 |
572 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PAK4-205 |
O96013 |
PAK4 |
Serine/threonine-protein kinase PAK 4 |
chr19 |
PF00069 |
321 |
572 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PAK4-202 |
O96013 |
PAK4 |
Serine/threonine-protein kinase PAK 4 |
chr19 |
PF00069 |
321 |
572 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PAK4-204 |
O96013 |
PAK4 |
Serine/threonine-protein kinase PAK 4 |
chr19 |
PF00069 |
321 |
572 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PAK4-203 |
O96013 |
PAK4 |
Serine/threonine-protein kinase PAK 4 |
chr19 |
PF00069 |
321 |
572 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PCID2-202 |
Q5JVF3 |
PCID2 |
PCI domain-containing protein 2 |
chr13 |
PF01399 |
277 |
388 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PCID2-205 |
Q5JVF3 |
PCID2 |
PCI domain-containing protein 2 |
chr13 |
PF01399 |
277 |
388 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PCID2-206 |
Q5JVF3 |
PCID2 |
PCI domain-containing protein 2 |
chr13 |
PF01399 |
277 |
388 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PCID2-204 |
Q5JVF3 |
PCID2 |
PCI domain-containing protein 2 |
chr13 |
PF01399 |
277 |
388 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PCID2-203 |
Q5JVF3 |
PCID2 |
PCI domain-containing protein 2 |
chr13 |
PF01399 |
277 |
388 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PCNA-202 |
P12004 |
PCNA |
Proliferating cell nuclear antigen |
chr20 |
PF00705 |
1 |
125 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PCNA-202 |
P12004 |
PCNA |
Proliferating cell nuclear antigen |
chr20 |
PF02747 |
127 |
254 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PCNA-201 |
P12004 |
PCNA |
Proliferating cell nuclear antigen |
chr20 |
PF00705 |
1 |
125 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PCNA-201 |
P12004 |
PCNA |
Proliferating cell nuclear antigen |
chr20 |
PF02747 |
127 |
254 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PDCD10-207 |
Q9BUL8 |
PDCD10 |
Programmed cell death protein 10 |
chr3 |
PF06840 |
14 |
161 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PDCD10-206 |
Q9BUL8 |
PDCD10 |
Programmed cell death protein 10 |
chr3 |
PF06840 |
14 |
161 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PDCD10-215 |
Q9BUL8 |
PDCD10 |
Programmed cell death protein 10 |
chr3 |
PF06840 |
14 |
161 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PDCD10-214 |
Q9BUL8 |
PDCD10 |
Programmed cell death protein 10 |
chr3 |
PF06840 |
14 |
161 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PDCD10-209 |
Q9BUL8 |
PDCD10 |
Programmed cell death protein 10 |
chr3 |
PF06840 |
14 |
161 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PDCD10-203 |
Q9BUL8 |
PDCD10 |
Programmed cell death protein 10 |
chr3 |
PF06840 |
14 |
161 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PDCD10-202 |
Q9BUL8 |
PDCD10 |
Programmed cell death protein 10 |
chr3 |
PF06840 |
14 |
161 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PDCD10-201 |
Q9BUL8 |
PDCD10 |
Programmed cell death protein 10 |
chr3 |
PF06840 |
14 |
161 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PDCD10-205 |
Q9BUL8 |
PDCD10 |
Programmed cell death protein 10 |
chr3 |
PF06840 |
14 |
161 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PDCD10-208 |
Q9BUL8 |
PDCD10 |
Programmed cell death protein 10 |
chr3 |
PF06840 |
14 |
161 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PDCD10-218 |
Q9BUL8 |
PDCD10 |
Programmed cell death protein 10 |
chr3 |
PF06840 |
14 |
161 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PDCD6-205 |
O75340 |
PDCD6 |
Programmed cell death protein 6 |
chr5 |
PF13499 |
92 |
156 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PDCD6-205 |
O75340 |
PDCD6 |
Programmed cell death protein 6 |
chr5 |
PF13202 |
30 |
53 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PDCD6-206 |
O75340 |
PDCD6 |
Programmed cell death protein 6 |
chr5 |
PF13499 |
92 |
156 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PDCD6-206 |
O75340 |
PDCD6 |
Programmed cell death protein 6 |
chr5 |
PF13202 |
30 |
53 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PDCD6-201 |
O75340 |
PDCD6 |
Programmed cell death protein 6 |
chr5 |
PF13499 |
92 |
156 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PDCD6-201 |
O75340 |
PDCD6 |
Programmed cell death protein 6 |
chr5 |
PF13202 |
30 |
53 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PDCD6-202 |
O75340 |
PDCD6 |
Programmed cell death protein 6 |
chr5 |
PF13499 |
92 |
156 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PDCD6-202 |
O75340 |
PDCD6 |
Programmed cell death protein 6 |
chr5 |
PF13202 |
30 |
53 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PDCD6IP-201 |
Q8WUM4 |
PDCD6IP |
Programmed cell death 6-interacting protein |
chr3 |
PF03097 |
4 |
378 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PDCD6IP-205 |
Q8WUM4 |
PDCD6IP |
Programmed cell death 6-interacting protein |
chr3 |
PF03097 |
4 |
378 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PDCD6IP-218 |
Q8WUM4 |
PDCD6IP |
Programmed cell death 6-interacting protein |
chr3 |
PF03097 |
4 |
378 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PDCD6IP-204 |
Q8WUM4 |
PDCD6IP |
Programmed cell death 6-interacting protein |
chr3 |
PF03097 |
4 |
378 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PDCD6IP-206 |
Q8WUM4 |
PDCD6IP |
Programmed cell death 6-interacting protein |
chr3 |
PF03097 |
4 |
378 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PDPK1-203 |
O15530 |
PDPK1 |
3-phosphoinositide-dependent protein kinase 1 |
chr16 |
PF00069 |
82 |
342 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PDPK1-202 |
O15530 |
PDPK1 |
3-phosphoinositide-dependent protein kinase 1 |
chr16 |
PF00069 |
82 |
342 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PDPK1-204 |
O15530 |
PDPK1 |
3-phosphoinositide-dependent protein kinase 1 |
chr16 |
PF00069 |
82 |
342 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PEX3-201 |
P56589 |
PEX3 |
Peroxisomal biogenesis factor 3 |
chr6 |
PF04882 |
94 |
364 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PEX5-206 |
P50542 |
PEX5 |
Peroxisomal targeting signal 1 receptor |
chr12 |
PF13181 |
556 |
589 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PEX5-209 |
P50542 |
PEX5 |
Peroxisomal targeting signal 1 receptor |
chr12 |
PF13181 |
556 |
589 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PEX5-215 |
P50542 |
PEX5 |
Peroxisomal targeting signal 1 receptor |
chr12 |
PF13181 |
556 |
589 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PEX5-207 |
P50542 |
PEX5 |
Peroxisomal targeting signal 1 receptor |
chr12 |
PF13181 |
556 |
589 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PEX5-213 |
P50542 |
PEX5 |
Peroxisomal targeting signal 1 receptor |
chr12 |
PF13181 |
556 |
589 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PEX5-221 |
P50542 |
PEX5 |
Peroxisomal targeting signal 1 receptor |
chr12 |
PF13181 |
556 |
589 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PEX5-204 |
P50542 |
PEX5 |
Peroxisomal targeting signal 1 receptor |
chr12 |
PF13181 |
556 |
589 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PEX5-205 |
P50542 |
PEX5 |
Peroxisomal targeting signal 1 receptor |
chr12 |
PF13181 |
556 |
589 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PEX5-217 |
P50542 |
PEX5 |
Peroxisomal targeting signal 1 receptor |
chr12 |
PF13181 |
556 |
589 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PEX5-202 |
P50542 |
PEX5 |
Peroxisomal targeting signal 1 receptor |
chr12 |
PF13181 |
556 |
589 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PFN1-201 |
P07737 |
PFN1 |
Profilin-1 |
chr17 |
PF00235 |
2 |
140 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PGC-204 |
P20142 |
PGC |
Gastricsin |
chr6 |
PF00026 |
72 |
387 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PGC-202 |
P20142 |
PGC |
Gastricsin |
chr6 |
PF00026 |
72 |
387 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PGR-202 |
P06401 |
PGR |
Progesterone receptor |
chr11 |
PF00104 |
704 |
891 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PIM1-201 |
P11309 |
PIM1 |
Serine/threonine-protein kinase pim-1 |
chr6 |
PF00069 |
38 |
290 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PLAU-203 |
P00749 |
PLAU |
Urokinase-type plasminogen activator |
chr10 |
PF00089 |
179 |
419 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PLAU-202 |
P00749 |
PLAU |
Urokinase-type plasminogen activator |
chr10 |
PF00089 |
179 |
419 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PLAU-201 |
P00749 |
PLAU |
Urokinase-type plasminogen activator |
chr10 |
PF00089 |
179 |
419 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PPARA-201 |
Q07869 |
PPARA |
Peroxisome proliferator-activated receptor alpha |
chr22 |
PF00104 |
264 |
449 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PPARA-202 |
Q07869 |
PPARA |
Peroxisome proliferator-activated receptor alpha |
chr22 |
PF00104 |
264 |
449 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PPARA-204 |
Q07869 |
PPARA |
Peroxisome proliferator-activated receptor alpha |
chr22 |
PF00104 |
264 |
449 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PPARG-205 |
P37231 |
PPARG |
Peroxisome proliferator-activated receptor gamma |
chr3 |
PF00104 |
299 |
486 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PPARG-202 |
P37231 |
PPARG |
Peroxisome proliferator-activated receptor gamma |
chr3 |
PF00104 |
299 |
486 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PPARG-227 |
P37231 |
PPARG |
Peroxisome proliferator-activated receptor gamma |
chr3 |
PF00104 |
299 |
486 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PPARG-201 |
P37231 |
PPARG |
Peroxisome proliferator-activated receptor gamma |
chr3 |
PF00104 |
299 |
486 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PPARG-229 |
P37231 |
PPARG |
Peroxisome proliferator-activated receptor gamma |
chr3 |
PF00104 |
299 |
486 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PPARG-206 |
P37231 |
PPARG |
Peroxisome proliferator-activated receptor gamma |
chr3 |
PF00104 |
299 |
486 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PPARG-224 |
P37231 |
PPARG |
Peroxisome proliferator-activated receptor gamma |
chr3 |
PF00104 |
299 |
486 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PPARG-208 |
P37231 |
PPARG |
Peroxisome proliferator-activated receptor gamma |
chr3 |
PF00104 |
299 |
486 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PPARG-215 |
P37231 |
PPARG |
Peroxisome proliferator-activated receptor gamma |
chr3 |
PF00104 |
299 |
486 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PPARG-222 |
P37231 |
PPARG |
Peroxisome proliferator-activated receptor gamma |
chr3 |
PF00104 |
299 |
486 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PPARG-216 |
P37231 |
PPARG |
Peroxisome proliferator-activated receptor gamma |
chr3 |
PF00104 |
299 |
486 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PPARG-214 |
P37231 |
PPARG |
Peroxisome proliferator-activated receptor gamma |
chr3 |
PF00104 |
299 |
486 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PPARG-217 |
P37231 |
PPARG |
Peroxisome proliferator-activated receptor gamma |
chr3 |
PF00104 |
299 |
486 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PPP1CA-214 |
P62136 |
PPP1CA |
Serine/threonine-protein phosphatase PP1-alpha catalytic subunit |
chr11 |
PF00149 |
57 |
252 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PPP1CA-203 |
P62136 |
PPP1CA |
Serine/threonine-protein phosphatase PP1-alpha catalytic subunit |
chr11 |
PF00149 |
57 |
252 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PPP1CA-201 |
P62136 |
PPP1CA |
Serine/threonine-protein phosphatase PP1-alpha catalytic subunit |
chr11 |
PF00149 |
57 |
252 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PPP3CA-202 |
Q08209 |
PPP3CA |
Protein phosphatase 3 catalytic subunit alpha |
chr4 |
PF00149 |
83 |
285 |
Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PPP3CA-203 |
Q08209 |
PPP3CA |
Protein phosphatase 3 catalytic subunit alpha |
chr4 |
PF00149 |
83 |
285 |
Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PRKACA-201 |
P17612 |
PRKACA |
cAMP-dependent protein kinase catalytic subunit alpha |
chr19 |
PF00069 |
44 |
298 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PRKACA-208 |
P17612 |
PRKACA |
cAMP-dependent protein kinase catalytic subunit alpha |
chr19 |
PF00069 |
44 |
298 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PRMT5-202 |
O14744 |
PRMT5 |
Protein arginine N-methyltransferase 5 |
chr14 |
PF05185 |
295 |
464 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PRMT5-204 |
O14744 |
PRMT5 |
Protein arginine N-methyltransferase 5 |
chr14 |
PF05185 |
295 |
464 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PTBP1-203 |
P26599 |
PTBP1 |
Polypyrimidine tract-binding protein 1 |
chr19 |
PF00076 |
456 |
521 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PTBP1-204 |
P26599 |
PTBP1 |
Polypyrimidine tract-binding protein 1 |
chr19 |
PF00076 |
456 |
521 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PTBP1-224 |
P26599 |
PTBP1 |
Polypyrimidine tract-binding protein 1 |
chr19 |
PF00076 |
456 |
521 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PTBP1-221 |
P26599 |
PTBP1 |
Polypyrimidine tract-binding protein 1 |
chr19 |
PF00076 |
456 |
521 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PTBP1-219 |
P26599 |
PTBP1 |
Polypyrimidine tract-binding protein 1 |
chr19 |
PF00076 |
456 |
521 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PTBP1-202 |
P26599 |
PTBP1 |
Polypyrimidine tract-binding protein 1 |
chr19 |
PF00076 |
456 |
521 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PTBP1-220 |
P26599 |
PTBP1 |
Polypyrimidine tract-binding protein 1 |
chr19 |
PF00076 |
456 |
521 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PTPN13-209 |
Q12923 |
PTPN13 |
Tyrosine-protein phosphatase non-receptor type 13 |
chr4 |
PF00595 |
1883 |
1961 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PTPN13-203 |
Q12923 |
PTPN13 |
Tyrosine-protein phosphatase non-receptor type 13 |
chr4 |
PF00595 |
1883 |
1961 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PTPN13-204 |
Q12923 |
PTPN13 |
Tyrosine-protein phosphatase non-receptor type 13 |
chr4 |
PF00595 |
1883 |
1961 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PTPN13-202 |
Q12923 |
PTPN13 |
Tyrosine-protein phosphatase non-receptor type 13 |
chr4 |
PF00595 |
1883 |
1961 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PTPN13-206 |
Q12923 |
PTPN13 |
Tyrosine-protein phosphatase non-receptor type 13 |
chr4 |
PF00595 |
1883 |
1961 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PTPN18-201 |
Q99952 |
PTPN18 |
Tyrosine-protein phosphatase non-receptor type 18 |
chr2 |
PF00102 |
56 |
290 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PTPN4-201 |
P29074 |
PTPN4 |
Tyrosine-protein phosphatase non-receptor type 4 |
chr2 |
PF00595 |
517 |
602 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| PTPN4-202 |
P29074 |
PTPN4 |
Tyrosine-protein phosphatase non-receptor type 4 |
chr2 |
PF00595 |
517 |
602 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| RARA-201 |
P10276 |
RARA |
Retinoic acid receptor alpha |
chr17 |
PF00104 |
224 |
401 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| RARA-208 |
P10276 |
RARA |
Retinoic acid receptor alpha |
chr17 |
PF00104 |
224 |
401 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| RARA-204 |
P10276 |
RARA |
Retinoic acid receptor alpha |
chr17 |
PF00104 |
224 |
401 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| RB1-209 |
P06400 |
RB1 |
Retinoblastoma-associated protein |
chr13 |
PF01857 |
646 |
765 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| RB1-201 |
P06400 |
RB1 |
Retinoblastoma-associated protein |
chr13 |
PF01857 |
646 |
765 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| RB1-208 |
P06400 |
RB1 |
Retinoblastoma-associated protein |
chr13 |
PF01857 |
646 |
765 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| RBBP4-217 |
Q09028 |
RBBP4 |
Histone-binding protein RBBP4 |
chr1 |
PF12265 |
19 |
88 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| RBBP4-217 |
Q09028 |
RBBP4 |
Histone-binding protein RBBP4 |
chr1 |
PF00400 |
364 |
403 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| RBBP4-206 |
Q09028 |
RBBP4 |
Histone-binding protein RBBP4 |
chr1 |
PF12265 |
19 |
88 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| RBBP4-206 |
Q09028 |
RBBP4 |
Histone-binding protein RBBP4 |
chr1 |
PF00400 |
364 |
403 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| RBBP4-211 |
Q09028 |
RBBP4 |
Histone-binding protein RBBP4 |
chr1 |
PF12265 |
19 |
88 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| RBBP4-211 |
Q09028 |
RBBP4 |
Histone-binding protein RBBP4 |
chr1 |
PF00400 |
364 |
403 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| RBBP4-214 |
Q09028 |
RBBP4 |
Histone-binding protein RBBP4 |
chr1 |
PF12265 |
19 |
88 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| RBBP4-214 |
Q09028 |
RBBP4 |
Histone-binding protein RBBP4 |
chr1 |
PF00400 |
364 |
403 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| RBBP4-202 |
Q09028 |
RBBP4 |
Histone-binding protein RBBP4 |
chr1 |
PF12265 |
19 |
88 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| RBBP4-202 |
Q09028 |
RBBP4 |
Histone-binding protein RBBP4 |
chr1 |
PF00400 |
364 |
403 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| RBBP4-218 |
Q09028 |
RBBP4 |
Histone-binding protein RBBP4 |
chr1 |
PF12265 |
19 |
88 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| RBBP4-218 |
Q09028 |
RBBP4 |
Histone-binding protein RBBP4 |
chr1 |
PF00400 |
364 |
403 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| RBBP4-201 |
Q09028 |
RBBP4 |
Histone-binding protein RBBP4 |
chr1 |
PF12265 |
19 |
88 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| RBBP4-201 |
Q09028 |
RBBP4 |
Histone-binding protein RBBP4 |
chr1 |
PF00400 |
364 |
403 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| RBBP4-204 |
Q09028 |
RBBP4 |
Histone-binding protein RBBP4 |
chr1 |
PF12265 |
19 |
88 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| RBBP4-204 |
Q09028 |
RBBP4 |
Histone-binding protein RBBP4 |
chr1 |
PF00400 |
364 |
403 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| RBBP7-204 |
Q16576 |
RBBP7 |
Histone-binding protein RBBP7 |
chrX |
PF00400 |
363 |
402 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| RBBP7-203 |
Q16576 |
RBBP7 |
Histone-binding protein RBBP7 |
chrX |
PF00400 |
363 |
402 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| RBM17-205 |
Q96I25 |
RBM17 |
Splicing factor 45 |
chr10 |
PF00076 |
323 |
383 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| RBM17-202 |
Q96I25 |
RBM17 |
Splicing factor 45 |
chr10 |
PF00076 |
323 |
383 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| RBM17-201 |
Q96I25 |
RBM17 |
Splicing factor 45 |
chr10 |
PF00076 |
323 |
383 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| RFXANK-201 |
O14593 |
RFXANK |
DNA-binding protein RFXANK |
chr19 |
PF00023 |
134 |
243 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| RFXANK-204 |
O14593 |
RFXANK |
DNA-binding protein RFXANK |
chr19 |
PF00023 |
134 |
243 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| RFXANK-203 |
O14593 |
RFXANK |
DNA-binding protein RFXANK |
chr19 |
PF00023 |
134 |
243 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| RIOX1-201 |
Q9H6W3 |
RIOX1 |
Ribosomal oxygenase 1 |
chr14 |
PF08007 |
215 |
557 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| RIOX2-202 |
Q8IUF8 |
RIOX2 |
Ribosomal oxygenase 2 |
chr3 |
PF08007 |
51 |
364 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| RIOX2-201 |
Q8IUF8 |
RIOX2 |
Ribosomal oxygenase 2 |
chr3 |
PF08007 |
51 |
364 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| RIOX2-206 |
Q8IUF8 |
RIOX2 |
Ribosomal oxygenase 2 |
chr3 |
PF08007 |
51 |
364 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| RIOX2-203 |
Q8IUF8 |
RIOX2 |
Ribosomal oxygenase 2 |
chr3 |
PF08007 |
51 |
364 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| RNF2-201 |
Q99496 |
RNF2 |
E3 ubiquitin-protein ligase RING2 |
chr1 |
PF16207 |
246 |
330 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| RNF2-202 |
Q99496 |
RNF2 |
E3 ubiquitin-protein ligase RING2 |
chr1 |
PF16207 |
246 |
330 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| RNF2-203 |
Q99496 |
RNF2 |
E3 ubiquitin-protein ligase RING2 |
chr1 |
PF16207 |
246 |
330 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| RNF31-201 |
Q96EP0 |
RNF31 |
E3 ubiquitin-protein ligase RNF31 |
chr14 |
PF09409 |
69 |
150 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| RNF31-229 |
Q96EP0 |
RNF31 |
E3 ubiquitin-protein ligase RNF31 |
chr14 |
PF09409 |
69 |
150 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| RORA-203 |
P35398 |
RORA |
Nuclear receptor ROR-alpha |
chr15 |
PF00104 |
305 |
494 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| RORC-201 |
P51449 |
RORC |
Nuclear receptor ROR-gamma |
chr1 |
PF00104 |
310 |
488 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| RORC-209 |
P51449 |
RORC |
Nuclear receptor ROR-gamma |
chr1 |
PF00104 |
310 |
488 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| RORC-202 |
P51449 |
RORC |
Nuclear receptor ROR-gamma |
chr1 |
PF00104 |
310 |
488 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| RPL11-203 |
P62913 |
RPL11 |
Large ribosomal subunit protein uL5 |
chr1 |
PF00281 |
10 |
63 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| RPL11-201 |
P62913 |
RPL11 |
Large ribosomal subunit protein uL5 |
chr1 |
PF00281 |
10 |
63 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| RPL11-206 |
P62913 |
RPL11 |
Large ribosomal subunit protein uL5 |
chr1 |
PF00281 |
10 |
63 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| RPRD1B-206 |
Q9NQG5 |
RPRD1B |
Regulation of nuclear pre-mRNA domain-containing protein 1B |
chr20 |
PF04818 |
7 |
125 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| RPRD1B-201 |
Q9NQG5 |
RPRD1B |
Regulation of nuclear pre-mRNA domain-containing protein 1B |
chr20 |
PF04818 |
7 |
125 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| RPRD1B-203 |
Q9NQG5 |
RPRD1B |
Regulation of nuclear pre-mRNA domain-containing protein 1B |
chr20 |
PF04818 |
7 |
125 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| RXRA-205 |
P19793 |
RXRA |
Retinoic acid receptor RXR-alpha |
chr9 |
PF00104 |
257 |
442 |
Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| RXRA-202 |
P19793 |
RXRA |
Retinoic acid receptor RXR-alpha |
chr9 |
PF00104 |
257 |
442 |
Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| S100A10-202 |
P60903 |
S100A10 |
Protein S100-A10 |
chr1 |
PF01023 |
5 |
44 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| S100A10-201 |
P60903 |
S100A10 |
Protein S100-A10 |
chr1 |
PF01023 |
5 |
44 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| S100A4-203 |
P26447 |
S100A4 |
Protein S100-A4 |
chr1 |
PF01023 |
5 |
47 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| S100A4-202 |
P26447 |
S100A4 |
Protein S100-A4 |
chr1 |
PF01023 |
5 |
47 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| S100A4-204 |
P26447 |
S100A4 |
Protein S100-A4 |
chr1 |
PF01023 |
5 |
47 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| S100A4-201 |
P26447 |
S100A4 |
Protein S100-A4 |
chr1 |
PF01023 |
5 |
47 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SDCBP-201 |
O00560 |
SDCBP |
Syntenin-1 |
chr8 |
PF00595 |
198 |
270 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SDCBP-212 |
O00560 |
SDCBP |
Syntenin-1 |
chr8 |
PF00595 |
198 |
270 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SDCBP-203 |
O00560 |
SDCBP |
Syntenin-1 |
chr8 |
PF00595 |
198 |
270 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SDCBP-202 |
O00560 |
SDCBP |
Syntenin-1 |
chr8 |
PF00595 |
198 |
270 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SDCBP-204 |
O00560 |
SDCBP |
Syntenin-1 |
chr8 |
PF00595 |
198 |
270 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SDCBP-213 |
O00560 |
SDCBP |
Syntenin-1 |
chr8 |
PF00595 |
198 |
270 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SERPINE1-201 |
P05121 |
SERPINE1 |
Plasminogen activator inhibitor 1 |
chr7 |
PF00079 |
33 |
402 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SETD7-202 |
Q8WTS6 |
SETD7 |
Histone-lysine N-methyltransferase SETD7 |
chr4 |
PF00856 |
170 |
336 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SETD7-201 |
Q8WTS6 |
SETD7 |
Histone-lysine N-methyltransferase SETD7 |
chr4 |
PF00856 |
170 |
336 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SF3B6-201 |
Q9Y3B4 |
SF3B6 |
Splicing factor 3B subunit 6 |
chr2 |
PF00076 |
21 |
88 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SH2D1A-214 |
O60880 |
SH2D1A |
SH2 domain-containing protein 1A |
chrX |
PF00017 |
6 |
87 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SH2D1A-202 |
O60880 |
SH2D1A |
SH2 domain-containing protein 1A |
chrX |
PF00017 |
6 |
87 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SH2D1A-212 |
O60880 |
SH2D1A |
SH2 domain-containing protein 1A |
chrX |
PF00017 |
6 |
87 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SH2D1A-213 |
O60880 |
SH2D1A |
SH2 domain-containing protein 1A |
chrX |
PF00017 |
6 |
87 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SH2D1A-201 |
O60880 |
SH2D1A |
SH2 domain-containing protein 1A |
chrX |
PF00017 |
6 |
87 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SH2D1A-209 |
O60880 |
SH2D1A |
SH2 domain-containing protein 1A |
chrX |
PF00017 |
6 |
87 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SH2D1A-205 |
O60880 |
SH2D1A |
SH2 domain-containing protein 1A |
chrX |
PF00017 |
6 |
87 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SIRT2-201 |
Q8IXJ6 |
SIRT2 |
NAD-dependent protein deacetylase sirtuin-2 |
chr19 |
PF02146 |
84 |
268 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SIRT2-204 |
Q8IXJ6 |
SIRT2 |
NAD-dependent protein deacetylase sirtuin-2 |
chr19 |
PF02146 |
84 |
268 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SIRT5-203 |
Q9NXA8 |
SIRT5 |
NAD-dependent protein deacylase sirtuin-5, mitochondrial |
chr6 |
PF02146 |
58 |
256 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SIRT5-213 |
Q9NXA8 |
SIRT5 |
NAD-dependent protein deacylase sirtuin-5, mitochondrial |
chr6 |
PF02146 |
58 |
256 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SIRT5-220 |
Q9NXA8 |
SIRT5 |
NAD-dependent protein deacylase sirtuin-5, mitochondrial |
chr6 |
PF02146 |
58 |
256 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SIRT5-204 |
Q9NXA8 |
SIRT5 |
NAD-dependent protein deacylase sirtuin-5, mitochondrial |
chr6 |
PF02146 |
58 |
256 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SIRT5-205 |
Q9NXA8 |
SIRT5 |
NAD-dependent protein deacylase sirtuin-5, mitochondrial |
chr6 |
PF02146 |
58 |
256 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SIRT5-217 |
Q9NXA8 |
SIRT5 |
NAD-dependent protein deacylase sirtuin-5, mitochondrial |
chr6 |
PF02146 |
58 |
256 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SIRT5-211 |
Q9NXA8 |
SIRT5 |
NAD-dependent protein deacylase sirtuin-5, mitochondrial |
chr6 |
PF02146 |
58 |
256 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SIRT5-221 |
Q9NXA8 |
SIRT5 |
NAD-dependent protein deacylase sirtuin-5, mitochondrial |
chr6 |
PF02146 |
58 |
256 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SIRT5-218 |
Q9NXA8 |
SIRT5 |
NAD-dependent protein deacylase sirtuin-5, mitochondrial |
chr6 |
PF02146 |
58 |
256 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SIRT5-223 |
Q9NXA8 |
SIRT5 |
NAD-dependent protein deacylase sirtuin-5, mitochondrial |
chr6 |
PF02146 |
58 |
256 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SIRT5-215 |
Q9NXA8 |
SIRT5 |
NAD-dependent protein deacylase sirtuin-5, mitochondrial |
chr6 |
PF02146 |
58 |
256 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SIRT5-212 |
Q9NXA8 |
SIRT5 |
NAD-dependent protein deacylase sirtuin-5, mitochondrial |
chr6 |
PF02146 |
58 |
256 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SIRT5-222 |
Q9NXA8 |
SIRT5 |
NAD-dependent protein deacylase sirtuin-5, mitochondrial |
chr6 |
PF02146 |
58 |
256 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SMAD2-208 |
Q15796 |
SMAD2 |
Mothers against decapentaplegic homolog 2 |
chr18 |
PF03166 |
272 |
443 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SMAD2-203 |
Q15796 |
SMAD2 |
Mothers against decapentaplegic homolog 2 |
chr18 |
PF03166 |
272 |
443 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SMAD2-207 |
Q15796 |
SMAD2 |
Mothers against decapentaplegic homolog 2 |
chr18 |
PF03166 |
272 |
443 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SMAD2-210 |
Q15796 |
SMAD2 |
Mothers against decapentaplegic homolog 2 |
chr18 |
PF03166 |
272 |
443 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SMAD2-211 |
Q15796 |
SMAD2 |
Mothers against decapentaplegic homolog 2 |
chr18 |
PF03166 |
272 |
443 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SMAD2-201 |
Q15796 |
SMAD2 |
Mothers against decapentaplegic homolog 2 |
chr18 |
PF03166 |
272 |
443 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SMAD2-204 |
Q15796 |
SMAD2 |
Mothers against decapentaplegic homolog 2 |
chr18 |
PF03166 |
272 |
443 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SMYD2-201 |
Q9NRG4 |
SMYD2 |
N-lysine methyltransferase SMYD2 |
chr1 |
PF01753 |
52 |
90 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SPIRE1-202 |
Q08AE8 |
SPIRE1 |
Protein spire homolog 1 |
chr18 |
PF16474 |
40 |
236 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SPIRE1-203 |
Q08AE8 |
SPIRE1 |
Protein spire homolog 1 |
chr18 |
PF16474 |
40 |
236 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SPOP-206 |
O43791 |
SPOP |
Speckle-type POZ protein |
chr17 |
PF00917 |
38 |
163 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SPOP-201 |
O43791 |
SPOP |
Speckle-type POZ protein |
chr17 |
PF00917 |
38 |
163 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SPOP-224 |
O43791 |
SPOP |
Speckle-type POZ protein |
chr17 |
PF00917 |
38 |
163 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SPOP-219 |
O43791 |
SPOP |
Speckle-type POZ protein |
chr17 |
PF00917 |
38 |
163 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SPOP-214 |
O43791 |
SPOP |
Speckle-type POZ protein |
chr17 |
PF00917 |
38 |
163 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SPOP-218 |
O43791 |
SPOP |
Speckle-type POZ protein |
chr17 |
PF00917 |
38 |
163 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SPOP-205 |
O43791 |
SPOP |
Speckle-type POZ protein |
chr17 |
PF00917 |
38 |
163 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SPOP-207 |
O43791 |
SPOP |
Speckle-type POZ protein |
chr17 |
PF00917 |
38 |
163 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SPOP-203 |
O43791 |
SPOP |
Speckle-type POZ protein |
chr17 |
PF00917 |
38 |
163 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SPOP-213 |
O43791 |
SPOP |
Speckle-type POZ protein |
chr17 |
PF00917 |
38 |
163 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SPOP-217 |
O43791 |
SPOP |
Speckle-type POZ protein |
chr17 |
PF00917 |
38 |
163 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SPOP-209 |
O43791 |
SPOP |
Speckle-type POZ protein |
chr17 |
PF00917 |
38 |
163 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SPOP-210 |
O43791 |
SPOP |
Speckle-type POZ protein |
chr17 |
PF00917 |
38 |
163 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SPOP-212 |
O43791 |
SPOP |
Speckle-type POZ protein |
chr17 |
PF00917 |
38 |
163 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SPOP-220 |
O43791 |
SPOP |
Speckle-type POZ protein |
chr17 |
PF00917 |
38 |
163 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SPOP-225 |
O43791 |
SPOP |
Speckle-type POZ protein |
chr17 |
PF00917 |
38 |
163 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SPOP-202 |
O43791 |
SPOP |
Speckle-type POZ protein |
chr17 |
PF00917 |
38 |
163 |
Census, Compendium |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SPSB1-201 |
Q96BD6 |
SPSB1 |
SPRY domain-containing SOCS box protein 1 |
chr1 |
PF00622 |
97 |
228 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SPSB1-202 |
Q96BD6 |
SPSB1 |
SPRY domain-containing SOCS box protein 1 |
chr1 |
PF00622 |
97 |
228 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SPSB1-204 |
Q96BD6 |
SPSB1 |
SPRY domain-containing SOCS box protein 1 |
chr1 |
PF00622 |
97 |
228 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SPSB1-203 |
Q96BD6 |
SPSB1 |
SPRY domain-containing SOCS box protein 1 |
chr1 |
PF00622 |
97 |
228 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SPSB2-204 |
Q99619 |
SPSB2 |
SPRY domain-containing SOCS box protein 2 |
chr12 |
PF00622 |
88 |
218 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SPSB2-205 |
Q99619 |
SPSB2 |
SPRY domain-containing SOCS box protein 2 |
chr12 |
PF00622 |
88 |
218 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SPSB2-201 |
Q99619 |
SPSB2 |
SPRY domain-containing SOCS box protein 2 |
chr12 |
PF00622 |
88 |
218 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| STAMBP-248 |
O95630 |
STAMBP |
STAM-binding protein |
chr2 |
PF08969 |
8 |
117 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| STAMBP-240 |
O95630 |
STAMBP |
STAM-binding protein |
chr2 |
PF08969 |
8 |
117 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| STAMBP-269 |
O95630 |
STAMBP |
STAM-binding protein |
chr2 |
PF08969 |
8 |
117 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| STAMBP-204 |
O95630 |
STAMBP |
STAM-binding protein |
chr2 |
PF08969 |
8 |
117 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| STAMBP-255 |
O95630 |
STAMBP |
STAM-binding protein |
chr2 |
PF08969 |
8 |
117 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| STAMBP-265 |
O95630 |
STAMBP |
STAM-binding protein |
chr2 |
PF08969 |
8 |
117 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| STAMBP-244 |
O95630 |
STAMBP |
STAM-binding protein |
chr2 |
PF08969 |
8 |
117 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| STAMBP-267 |
O95630 |
STAMBP |
STAM-binding protein |
chr2 |
PF08969 |
8 |
117 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| STAMBP-202 |
O95630 |
STAMBP |
STAM-binding protein |
chr2 |
PF08969 |
8 |
117 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| STAMBP-221 |
O95630 |
STAMBP |
STAM-binding protein |
chr2 |
PF08969 |
8 |
117 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| STAMBP-257 |
O95630 |
STAMBP |
STAM-binding protein |
chr2 |
PF08969 |
8 |
117 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| STAMBP-241 |
O95630 |
STAMBP |
STAM-binding protein |
chr2 |
PF08969 |
8 |
117 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| STAMBP-256 |
O95630 |
STAMBP |
STAM-binding protein |
chr2 |
PF08969 |
8 |
117 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| STAMBP-234 |
O95630 |
STAMBP |
STAM-binding protein |
chr2 |
PF08969 |
8 |
117 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| STAMBP-262 |
O95630 |
STAMBP |
STAM-binding protein |
chr2 |
PF08969 |
8 |
117 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| STAMBP-227 |
O95630 |
STAMBP |
STAM-binding protein |
chr2 |
PF08969 |
8 |
117 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| STAMBP-243 |
O95630 |
STAMBP |
STAM-binding protein |
chr2 |
PF08969 |
8 |
117 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| STAMBP-219 |
O95630 |
STAMBP |
STAM-binding protein |
chr2 |
PF08969 |
8 |
117 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| STAMBP-239 |
O95630 |
STAMBP |
STAM-binding protein |
chr2 |
PF08969 |
8 |
117 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| STAMBP-249 |
O95630 |
STAMBP |
STAM-binding protein |
chr2 |
PF08969 |
8 |
117 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| STAMBP-233 |
O95630 |
STAMBP |
STAM-binding protein |
chr2 |
PF08969 |
8 |
117 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| STAMBP-203 |
O95630 |
STAMBP |
STAM-binding protein |
chr2 |
PF08969 |
8 |
117 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| STAMBP-212 |
O95630 |
STAMBP |
STAM-binding protein |
chr2 |
PF08969 |
8 |
117 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| STAMBP-213 |
O95630 |
STAMBP |
STAM-binding protein |
chr2 |
PF08969 |
8 |
117 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| STAMBP-201 |
O95630 |
STAMBP |
STAM-binding protein |
chr2 |
PF08969 |
8 |
117 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| STAMBP-270 |
O95630 |
STAMBP |
STAM-binding protein |
chr2 |
PF08969 |
8 |
117 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| STAMBP-222 |
O95630 |
STAMBP |
STAM-binding protein |
chr2 |
PF08969 |
8 |
117 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| STAMBP-251 |
O95630 |
STAMBP |
STAM-binding protein |
chr2 |
PF08969 |
8 |
117 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| STAMBP-246 |
O95630 |
STAMBP |
STAM-binding protein |
chr2 |
PF08969 |
8 |
117 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| STAMBP-220 |
O95630 |
STAMBP |
STAM-binding protein |
chr2 |
PF08969 |
8 |
117 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| STAMBP-225 |
O95630 |
STAMBP |
STAM-binding protein |
chr2 |
PF08969 |
8 |
117 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| STAMBP-271 |
O95630 |
STAMBP |
STAM-binding protein |
chr2 |
PF08969 |
8 |
117 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| STAMBP-218 |
O95630 |
STAMBP |
STAM-binding protein |
chr2 |
PF08969 |
8 |
117 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| STAMBP-260 |
O95630 |
STAMBP |
STAM-binding protein |
chr2 |
PF08969 |
8 |
117 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| STAMBP-252 |
O95630 |
STAMBP |
STAM-binding protein |
chr2 |
PF08969 |
8 |
117 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| STAMBP-264 |
O95630 |
STAMBP |
STAM-binding protein |
chr2 |
PF08969 |
8 |
117 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| STAMBP-237 |
O95630 |
STAMBP |
STAM-binding protein |
chr2 |
PF08969 |
8 |
117 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| STAMBP-268 |
O95630 |
STAMBP |
STAM-binding protein |
chr2 |
PF08969 |
8 |
117 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| STAMBP-253 |
O95630 |
STAMBP |
STAM-binding protein |
chr2 |
PF08969 |
8 |
117 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| STAMBP-231 |
O95630 |
STAMBP |
STAM-binding protein |
chr2 |
PF08969 |
8 |
117 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| STAMBP-250 |
O95630 |
STAMBP |
STAM-binding protein |
chr2 |
PF08969 |
8 |
117 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| STAMBP-216 |
O95630 |
STAMBP |
STAM-binding protein |
chr2 |
PF08969 |
8 |
117 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| STAMBP-226 |
O95630 |
STAMBP |
STAM-binding protein |
chr2 |
PF08969 |
8 |
117 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| STAMBP-254 |
O95630 |
STAMBP |
STAM-binding protein |
chr2 |
PF08969 |
8 |
117 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| STAMBP-266 |
O95630 |
STAMBP |
STAM-binding protein |
chr2 |
PF08969 |
8 |
117 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| STAMBP-263 |
O95630 |
STAMBP |
STAM-binding protein |
chr2 |
PF08969 |
8 |
117 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| STAMBP-208 |
O95630 |
STAMBP |
STAM-binding protein |
chr2 |
PF08969 |
8 |
117 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| STAMBP-261 |
O95630 |
STAMBP |
STAM-binding protein |
chr2 |
PF08969 |
8 |
117 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| STAMBP-259 |
O95630 |
STAMBP |
STAM-binding protein |
chr2 |
PF08969 |
8 |
117 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| STIP1-201 |
P31948 |
STIP1 |
Stress-induced-phosphoprotein 1 |
chr11 |
PF13181 |
428 |
461 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| STIP1-201 |
P31948 |
STIP1 |
Stress-induced-phosphoprotein 1 |
chr11 |
PF00515 |
36 |
69 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| STIP1-203 |
P31948 |
STIP1 |
Stress-induced-phosphoprotein 1 |
chr11 |
PF13181 |
428 |
461 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| STIP1-203 |
P31948 |
STIP1 |
Stress-induced-phosphoprotein 1 |
chr11 |
PF00515 |
36 |
69 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SUFU-202 |
Q9UMX1 |
SUFU |
Suppressor of fused homolog |
chr10 |
PF05076 |
64 |
241 |
Census |
Yes
|
0 |
0.00 % |
0 |
0.00 % |
link |
| SUMF1-201 |
Q8NBK3 |
SUMF1 |
Formylglycine-generating enzyme |
chr3 |
PF03781 |
87 |
367 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| TAX1BP3-201 |
O14907 |
TAX1BP3 |
Tax1-binding protein 3 |
chr17 |
PF00595 |
17 |
110 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| TERF2-201 |
Q15554 |
TERF2 |
Telomeric repeat-binding factor 2 |
chr16 |
PF08558 |
94 |
293 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| TIAM1-203 |
Q13009 |
TIAM1 |
Rho guanine nucleotide exchange factor TIAM1 |
chr21 |
PF00595 |
845 |
925 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| TIAM1-208 |
Q13009 |
TIAM1 |
Rho guanine nucleotide exchange factor TIAM1 |
chr21 |
PF00595 |
845 |
925 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| TIAM1-201 |
Q13009 |
TIAM1 |
Rho guanine nucleotide exchange factor TIAM1 |
chr21 |
PF00595 |
845 |
925 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| TIAM1-206 |
Q13009 |
TIAM1 |
Rho guanine nucleotide exchange factor TIAM1 |
chr21 |
PF00595 |
845 |
925 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| TJP1-202 |
Q07157 |
TJP1 |
Tight junction protein ZO-1 |
chr15 |
PF00595 |
422 |
501 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| TJP1-202 |
Q07157 |
TJP1 |
Tight junction protein ZO-1 |
chr15 |
PF07653 |
520 |
582 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| TJP1-211 |
Q07157 |
TJP1 |
Tight junction protein ZO-1 |
chr15 |
PF00595 |
422 |
501 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| TJP1-211 |
Q07157 |
TJP1 |
Tight junction protein ZO-1 |
chr15 |
PF07653 |
520 |
582 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| TJP1-201 |
Q07157 |
TJP1 |
Tight junction protein ZO-1 |
chr15 |
PF00595 |
422 |
501 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| TJP1-201 |
Q07157 |
TJP1 |
Tight junction protein ZO-1 |
chr15 |
PF07653 |
520 |
582 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| TLE1-203 |
Q04724 |
TLE1 |
Transducin-like enhancer protein 1 |
chr9 |
PF00400 |
606 |
644 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| TNKS2-202 |
Q9H2K2 |
TNKS2 |
Poly [ADP-ribose] polymerase tankyrase-2 |
chr10 |
PF13637 |
679 |
732 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| TNKS2-202 |
Q9H2K2 |
TNKS2 |
Poly [ADP-ribose] polymerase tankyrase-2 |
chr10 |
PF12796 |
556 |
622 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| TNKS2-201 |
Q9H2K2 |
TNKS2 |
Poly [ADP-ribose] polymerase tankyrase-2 |
chr10 |
PF13637 |
679 |
732 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| TNKS2-201 |
Q9H2K2 |
TNKS2 |
Poly [ADP-ribose] polymerase tankyrase-2 |
chr10 |
PF12796 |
556 |
622 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| TNPO1-218 |
Q92973 |
TNPO1 |
Transportin-1 |
chr5 |
PF03810 |
41 |
109 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| TNPO1-215 |
Q92973 |
TNPO1 |
Transportin-1 |
chr5 |
PF03810 |
41 |
109 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| TNPO1-204 |
Q92973 |
TNPO1 |
Transportin-1 |
chr5 |
PF03810 |
41 |
109 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| TNPO1-201 |
Q92973 |
TNPO1 |
Transportin-1 |
chr5 |
PF03810 |
41 |
109 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| TP53BP1-210 |
Q12888 |
TP53BP1 |
TP53-binding protein 1 |
chr15 |
PF09038 |
1483 |
1604 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| TP53BP1-201 |
Q12888 |
TP53BP1 |
TP53-binding protein 1 |
chr15 |
PF09038 |
1483 |
1604 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| TP53BP1-203 |
Q12888 |
TP53BP1 |
TP53-binding protein 1 |
chr15 |
PF09038 |
1483 |
1604 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| TPST2-205 |
O60704 |
TPST2 |
Protein-tyrosine sulfotransferase 2 |
chr22 |
PF13469 |
69 |
262 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| TPST2-203 |
O60704 |
TPST2 |
Protein-tyrosine sulfotransferase 2 |
chr22 |
PF13469 |
69 |
262 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| TPST2-209 |
O60704 |
TPST2 |
Protein-tyrosine sulfotransferase 2 |
chr22 |
PF13469 |
69 |
262 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| TPST2-202 |
O60704 |
TPST2 |
Protein-tyrosine sulfotransferase 2 |
chr22 |
PF13469 |
69 |
262 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| TPST2-201 |
O60704 |
TPST2 |
Protein-tyrosine sulfotransferase 2 |
chr22 |
PF13469 |
69 |
262 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| TSG101-204 |
Q99816 |
TSG101 |
Tumor susceptibility gene 101 protein |
chr11 |
PF05743 |
21 |
141 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| TSG101-201 |
Q99816 |
TSG101 |
Tumor susceptibility gene 101 protein |
chr11 |
PF05743 |
21 |
141 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| TYMS-202 |
P04818 |
TYMS |
Thymidylate synthase |
chr18 |
PF00303 |
31 |
313 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| TYMS-203 |
P04818 |
TYMS |
Thymidylate synthase |
chr18 |
PF00303 |
31 |
313 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| UBE2B-207 |
P63146 |
UBE2B |
Ubiquitin-conjugating enzyme E2 B |
chr5 |
PF00179 |
8 |
145 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| UBE2B-201 |
P63146 |
UBE2B |
Ubiquitin-conjugating enzyme E2 B |
chr5 |
PF00179 |
8 |
145 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| UHRF1-203 |
Q96T88 |
UHRF1 |
E3 ubiquitin-protein ligase UHRF1 |
chr19 |
PF00628 |
317 |
366 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| UHRF1-207 |
Q96T88 |
UHRF1 |
E3 ubiquitin-protein ligase UHRF1 |
chr19 |
PF00628 |
317 |
366 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| UHRF1-206 |
Q96T88 |
UHRF1 |
E3 ubiquitin-protein ligase UHRF1 |
chr19 |
PF00628 |
317 |
366 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| UHRF1-204 |
Q96T88 |
UHRF1 |
E3 ubiquitin-protein ligase UHRF1 |
chr19 |
PF00628 |
317 |
366 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| UHRF1-201 |
Q96T88 |
UHRF1 |
E3 ubiquitin-protein ligase UHRF1 |
chr19 |
PF00628 |
317 |
366 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| UHRF1-205 |
Q96T88 |
UHRF1 |
E3 ubiquitin-protein ligase UHRF1 |
chr19 |
PF00628 |
317 |
366 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| UHRF1-208 |
Q96T88 |
UHRF1 |
E3 ubiquitin-protein ligase UHRF1 |
chr19 |
PF00628 |
317 |
366 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| USP7-201 |
Q93009 |
USP7 |
Ubiquitin carboxyl-terminal hydrolase 7 |
chr16 |
PF00917 |
74 |
196 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| USP7-202 |
Q93009 |
USP7 |
Ubiquitin carboxyl-terminal hydrolase 7 |
chr16 |
PF00917 |
74 |
196 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| USP7-222 |
Q93009 |
USP7 |
Ubiquitin carboxyl-terminal hydrolase 7 |
chr16 |
PF00917 |
74 |
196 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| VPS4B-201 |
O75351 |
VPS4B |
Vacuolar protein sorting-associated protein 4B |
chr18 |
PF04212 |
8 |
74 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| VPS4B-202 |
O75351 |
VPS4B |
Vacuolar protein sorting-associated protein 4B |
chr18 |
PF04212 |
8 |
74 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| VTA1-202 |
Q9NP79 |
VTA1 |
Vacuolar protein sorting-associated protein VTA1 homolog |
chr6 |
PF04652 |
16 |
158 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| WDR5-202 |
P61964 |
WDR5 |
WD repeat-containing protein 5 |
chr9 |
PF00400 |
291 |
331 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| WDR5-201 |
P61964 |
WDR5 |
WD repeat-containing protein 5 |
chr9 |
PF00400 |
291 |
331 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| WDR5-203 |
P61964 |
WDR5 |
WD repeat-containing protein 5 |
chr9 |
PF00400 |
291 |
331 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| YWHAZ-210 |
P63104 |
YWHAZ |
14-3-3 protein zeta/delta |
chr8 |
PF00244 |
9 |
229 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| YWHAZ-208 |
P63104 |
YWHAZ |
14-3-3 protein zeta/delta |
chr8 |
PF00244 |
9 |
229 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| YWHAZ-205 |
P63104 |
YWHAZ |
14-3-3 protein zeta/delta |
chr8 |
PF00244 |
9 |
229 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| YWHAZ-223 |
P63104 |
YWHAZ |
14-3-3 protein zeta/delta |
chr8 |
PF00244 |
9 |
229 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| YWHAZ-221 |
P63104 |
YWHAZ |
14-3-3 protein zeta/delta |
chr8 |
PF00244 |
9 |
229 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| YWHAZ-203 |
P63104 |
YWHAZ |
14-3-3 protein zeta/delta |
chr8 |
PF00244 |
9 |
229 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| YWHAZ-217 |
P63104 |
YWHAZ |
14-3-3 protein zeta/delta |
chr8 |
PF00244 |
9 |
229 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| YWHAZ-201 |
P63104 |
YWHAZ |
14-3-3 protein zeta/delta |
chr8 |
PF00244 |
9 |
229 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| YWHAZ-204 |
P63104 |
YWHAZ |
14-3-3 protein zeta/delta |
chr8 |
PF00244 |
9 |
229 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| YWHAZ-209 |
P63104 |
YWHAZ |
14-3-3 protein zeta/delta |
chr8 |
PF00244 |
9 |
229 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| YWHAZ-218 |
P63104 |
YWHAZ |
14-3-3 protein zeta/delta |
chr8 |
PF00244 |
9 |
229 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| YWHAZ-206 |
P63104 |
YWHAZ |
14-3-3 protein zeta/delta |
chr8 |
PF00244 |
9 |
229 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| YWHAZ-207 |
P63104 |
YWHAZ |
14-3-3 protein zeta/delta |
chr8 |
PF00244 |
9 |
229 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |
| YWHAZ-211 |
P63104 |
YWHAZ |
14-3-3 protein zeta/delta |
chr8 |
PF00244 |
9 |
229 |
Not Cancer Driver |
No
|
0 |
0.00 % |
0 |
0.00 % |
link |